This document provides evidence-based recommendations for point-of-care lung ultrasound from an international panel of 28 experts. The panel reviewed literature from 1966 to 2011 using the GRADE method to determine evidence quality and develop recommendations. They discussed 73 proposed statements over three conferences using a modified Delphi technique and anonymous voting. Strong recommendations were made for 65 statements, and weak recommendations for 2 statements. The recommendations aim to standardize the application of lung ultrasound in clinical settings and provide a framework to guide its future use and research.
Oral presentation ICC-PBM 2018 @ G-I-N conference Manchester (UK) 2018CEBaP_rkv
The document describes how an international consensus conference on patient blood management (ICC-PBM) integrated the GRADE approach and a formal consensus methodology. A scientific committee formulated 17 questions to guide 3 topics of interest. A 2-day conference included 200 medical experts from 10 disciplines who reviewed evidence using GRADE. It included open sessions for evidence presentation, discussion, and closed executive sessions where decision-making panels drafted recommendations. The process aimed to develop transparent, evidence-based consensus guidelines for optimizing patient blood management.
REG PCORI Grant Planning Meeting 26/09/15Zoe Mitchell
The document outlines an agenda for a planning meeting between the Respiratory Effectiveness Group (REG) and the Patient-Centered Outcomes Research Institute (PCORI) to discuss potential comparative effectiveness research collaborations. Key items on the agenda include aligning the missions of REG and PCORI, discussing what comparative effectiveness research entails, engaging stakeholders, and generating ideas for potential research topics that could be funded through PCORI. The meeting aims to identify topics of interest to both organizations that incorporate patient-centered outcomes research.
The document summarizes discussions from an IPF/ILD Working Group meeting. It provides updates on several studies, including one characterizing the clinical features and healthcare utilization of IPF patients in the years before diagnosis. The study found increased healthcare resource use in the 2 years prior to an IPF diagnosis. Another study aims to evaluate diagnostic agreement across global sites. The working group discussed priorities for future research, including a Phase II study using digitized patient cases to assess diagnostic accuracy across different healthcare settings.
This document summarizes the minutes from a technology working group meeting. It provides updates on recent publications and ongoing studies. One study is using healthcare claims data to characterize frequent exacerbators of asthma and identify risk factors for future exacerbations. Another proposed study would develop checklists to guide developers in creating relevant respiratory technologies. Additional proposed studies include examining behavior change theories for digital health solutions and optimizing triple therapy for COPD patients. The group discussed prioritizing future research projects and ensuring selected priorities are pursued through funding.
The document summarizes a study that evaluated methods for selecting pregnant or postpartum women with suspected pulmonary embolism (PE) for diagnostic imaging. The study aimed to estimate the accuracy, effectiveness and cost-effectiveness of using clinical features, decision rules and biomarkers to identify which patients need imaging. The study developed a diagnostic model to analyze the performance of these selection methods and assess their ability to safely reduce imaging while maintaining appropriate patient care.
The document provides details about an upcoming annual general meeting for the Respiratory Effectiveness Group (REG). The meeting will take place on September 26th at the Wyndham Apollo Hotel in Amsterdam. David Price will chair the meeting, which will review REG's activities from 2013 to 2015 and look ahead to future opportunities. Some of the key accomplishments highlighted include establishing a global network of over 270 collaborators across 38 countries, running numerous research studies and task forces, publishing several papers and abstracts, and hosting successful summits in 2014 and 2015. The meeting aims to further develop REG's working groups and collaborative activities to generate real-world evidence that can guide clinical practice and policy.
An overview of the work and initial results of the REG-EAACI Taskforce assessing the quality of literature in the field of real-world respiratory medicine.
Oral presentation ICC-PBM 2018 @ G-I-N conference Manchester (UK) 2018CEBaP_rkv
The document describes how an international consensus conference on patient blood management (ICC-PBM) integrated the GRADE approach and a formal consensus methodology. A scientific committee formulated 17 questions to guide 3 topics of interest. A 2-day conference included 200 medical experts from 10 disciplines who reviewed evidence using GRADE. It included open sessions for evidence presentation, discussion, and closed executive sessions where decision-making panels drafted recommendations. The process aimed to develop transparent, evidence-based consensus guidelines for optimizing patient blood management.
REG PCORI Grant Planning Meeting 26/09/15Zoe Mitchell
The document outlines an agenda for a planning meeting between the Respiratory Effectiveness Group (REG) and the Patient-Centered Outcomes Research Institute (PCORI) to discuss potential comparative effectiveness research collaborations. Key items on the agenda include aligning the missions of REG and PCORI, discussing what comparative effectiveness research entails, engaging stakeholders, and generating ideas for potential research topics that could be funded through PCORI. The meeting aims to identify topics of interest to both organizations that incorporate patient-centered outcomes research.
The document summarizes discussions from an IPF/ILD Working Group meeting. It provides updates on several studies, including one characterizing the clinical features and healthcare utilization of IPF patients in the years before diagnosis. The study found increased healthcare resource use in the 2 years prior to an IPF diagnosis. Another study aims to evaluate diagnostic agreement across global sites. The working group discussed priorities for future research, including a Phase II study using digitized patient cases to assess diagnostic accuracy across different healthcare settings.
This document summarizes the minutes from a technology working group meeting. It provides updates on recent publications and ongoing studies. One study is using healthcare claims data to characterize frequent exacerbators of asthma and identify risk factors for future exacerbations. Another proposed study would develop checklists to guide developers in creating relevant respiratory technologies. Additional proposed studies include examining behavior change theories for digital health solutions and optimizing triple therapy for COPD patients. The group discussed prioritizing future research projects and ensuring selected priorities are pursued through funding.
The document summarizes a study that evaluated methods for selecting pregnant or postpartum women with suspected pulmonary embolism (PE) for diagnostic imaging. The study aimed to estimate the accuracy, effectiveness and cost-effectiveness of using clinical features, decision rules and biomarkers to identify which patients need imaging. The study developed a diagnostic model to analyze the performance of these selection methods and assess their ability to safely reduce imaging while maintaining appropriate patient care.
The document provides details about an upcoming annual general meeting for the Respiratory Effectiveness Group (REG). The meeting will take place on September 26th at the Wyndham Apollo Hotel in Amsterdam. David Price will chair the meeting, which will review REG's activities from 2013 to 2015 and look ahead to future opportunities. Some of the key accomplishments highlighted include establishing a global network of over 270 collaborators across 38 countries, running numerous research studies and task forces, publishing several papers and abstracts, and hosting successful summits in 2014 and 2015. The meeting aims to further develop REG's working groups and collaborative activities to generate real-world evidence that can guide clinical practice and policy.
An overview of the work and initial results of the REG-EAACI Taskforce assessing the quality of literature in the field of real-world respiratory medicine.
REG Adherence Working Group Meeting 26/09/15Zoe Mitchell
This document provides a summary of an upcoming meeting on asthma treatment adherence. The meeting will take place on September 26th in Amsterdam. It will be chaired by Eric van Ganse and focus on a bidirectional adherence study being conducted by an international research team. The study is analyzing the relationship between adherence to asthma treatment and asthma-related health outcomes using data from an electronic health records database. The agenda includes updates on the study design, measures of adherence and health outcomes, and initial analyses. Next steps for the study and opportunities to present preliminary findings are also discussed.
REG Technologies Working Group Meeting 26/09/15Zoe Mitchell
This document provides an agenda and notes from a meeting of the Technologies Working Group of the Respiratory Effectiveness Group (REG). The meeting objectives were to agree terms of reference for the group, discuss initial seed projects, and identify 1-2 longer term projects. Under terms of reference, the group will focus on technology-based solutions for chronic respiratory conditions, with a focus on monitoring and behavioral change. Initial seed project ideas discussed included evaluating practices for developing technology solutions, a literature review on using health information to change patient behavior, and optimizing technology interfaces for older patients. Preliminary data from a PhD student's survey of stakeholder attitudes towards smart inhalers was also presented. The group discussed potential future projects and grant opportunities.
REG IPF/ILD Working Group Meeting 25/09/15Zoe Mitchell
The document outlines plans for two diagnostic studies in interstitial lung disease (ILD). [1] Phase I will characterize ILD diagnostic practices globally, especially in underrepresented regions, to inform the design of [2] Phase II which will evaluate agreement and accuracy of ILD multidisciplinary team diagnoses across sites. The studies aim to establish best practice recommendations for optimizing the pathway to accurate ILD diagnosis.
This document summarizes a study that assessed current practices in teaching life support competencies in healthcare. The study conducted surveys to: 1) Identify life support courses provided in UK hospitals and required by professional bodies, 2) Describe curriculum content and teaching methods of popular in-hospital courses, 3) Examine fidelity of implementation of courses in England. The study found that most NHS hospitals provide adult life support courses, with the Resuscitation Council UK Advanced Life Support course most common. Many hospitals also provide in-house courses. Recognition and management of pre-arrest deterioration are now widely taught. While life support training is provided in all medical schools, approaches vary and pre-arrest management courses are less common. Only a
The meeting provided updates on current adherence projects and discussed ideas for future projects. For the current project on the bidirectional relationship between asthma outcomes and adherence, preliminary conclusions from Phase 2 were presented showing weak associations between adherence and control. Limitations were noted and next steps discussed. Two existing ideas for future studies using pharmacy and technology-based approaches were assessed for ongoing relevance, feasibility, validity and priority. New projects presented included a device optimization study and a project on age-related changes in childhood adherence and outcomes. Prioritization of adherence research needs and ensuring pursued priorities closed the discussion.
REG Interstitial Lung Disease Working Group MeetingZoe Mitchell
The meeting agenda included:
1) Introductions of working group members and REG supporters in attendance.
2) An overview of the Respiratory Effectiveness Group (REG) and its mission to conduct real-world respiratory research.
3) A discussion of potential research ideas led by Luca Richeldi, including characterizing healthcare utilization prior to ILD diagnosis, using electronic lung sounds for early diagnosis, and evaluating consistency of ILD diagnoses across multidisciplinary teams.
4) A final group discussion on other opportunities for collaboration within the ILD working group.
Inadequate management of asthma can lead to physical handicap and death. The study aimedto assess knowledge and practice of
asthmatic participants for use meter dose inhaler device. A descriptive study involved 105 participants, conducted at public
hospitals in Khartoum state from July to October2014. Questionnaire and observational check list were used for data collection.
The study enrolled (51%) female and (49%) male. Most of participants their age group ranged, between 36 to 45 years, (35%)
were workers and (31%) received University education while 44 % had a chronic asthma. Level of participant’s knowledge was a
very good regard care and storage of the device; sequent (77% - 79%). There were(64%) had moderate level of knowledge for
preparation dose (69%) replacing inhaler device and cleaning mouthpiece (60%), while 56% had very poor knowledge to rinse
mouth after puff. A highly significant difference between the level of knowledge and education (P value<0.001) regard replacing
the inhaler device, and cleansing mouthpiece. All participants demonstrated correct technique of using inhaler device, position,
removed, pressed replacement the cap, shaking inhaler device and took deep breath. While half of them had moderate skill level
for opened mouth technique, continuous breathing and rinsed mouth after puffuse, and fewer of participants had poor technique
during repeating the puff. Most of participants reflected moderate to poor level of knowledge and have very good practice for
correct used inhaler meter device; this reveals the discrepancy between knowledge and practice.
This document provides guidelines for evaluating patients with pulmonary nodules from the American College of Chest Physicians. It summarizes the guideline objectives, target population, diagnostic and management interventions considered, major outcomes, methodology, recommendations, and validation process. The guideline was developed through a systematic review of literature and expert consensus to provide evidence-based recommendations. It defines solitary pulmonary nodules and provides 12 major recommendations on pre-test probability assessment, imaging tests, PET scanning, discussion of risks/benefits with patients, and tissue diagnosis.
This document discusses maximizing patient outcomes in respiratory care. It outlines the founding principles of the Respiratory Effectiveness Group (REG), which aims to better integrate real-world evidence from sources like observational studies and pragmatic trials into clinical practice guidelines. Currently, guidelines are often based primarily on randomized controlled trials, which have limitations and may not generalize to most patients. The document calls for considering a diversity of evidence and tailoring care to individual patient needs and characteristics. It also discusses how databases could help achieve more personalized care by providing real-world data on topics like disease prevalence, treatments, and outcomes across different healthcare systems.
Severe Asthma/Biomarkers Working Group ERS 2017Kathryn Brown
The document summarizes a meeting of the Severe Asthma/Biomarkers Joint Working Group. It includes an agenda for presentations on recent and ongoing projects related to using biomarkers like FeNO and blood eosinophils to predict outcomes in severe asthma. Presentations covered recent publications on these topics, updates on registry initiatives like ISAR and available data sources like OPCRD, and ideas for new projects. Attendees also discussed previous ideas around further evaluating biomarkers as predictors of treatment response and clinical outcomes.
This document summarizes the agenda and key discussion points for several committee meetings taking place on September 26th in Amsterdam. The Research Review committee will discuss priorities for funding respiratory research studies in 2015/2016. They will also evaluate the process for soliciting and reviewing research ideas. The Accreditation committee will discuss accrediting researchers. The Manuscript Review committee will examine their publication process and output over the past year. Overall, the meetings aim to strategize how the organization can best support high-quality respiratory research through prioritizing ideas, funding studies, and disseminating results.
ATS Symposium: Leukotriene Antagonists As First-line Asthma Controller For St...Zoe Mitchell
ATS Symposium session presented by Prof. David Price:
Leukotriene Antagonists As First-line Asthma Controller For Step 2
Presented May 2015 at ATS 2015, Denver, Colorado, USA
This document summarizes the proceedings of the Small Airways Working Group Meeting held on September 9th, 2017 in Milan. It includes the agenda, list of attendees, and progress updates on several studies. Multiple studies comparing the effectiveness of extra-fine particle inhaled corticosteroids to fine particle ICS have been published or are underway. Preliminary results suggest extra-fine ICS may achieve better asthma control at lower doses and with fewer side effects like pneumonia. The group discussed potential future studies on flexible dosing strategies, metabolic effects of high dose ICS, and the impact of particle size in patients with obesity or GERD. Priority research areas and ongoing protocols were reviewed for continued relevance and feasibility.
REG COPD Control Working Group MeetingZoe Mitchell
1. The REG COPD Control Working Group met on May 17th in Denver, Colorado to discuss plans to validate the concept of control in COPD through several research studies.
2. These included a non-interventional database study using the UK OPCRD, two Spanish pilot studies on changes in control versus severity and symptoms, and an international prospective study to validate the concept of control.
3. The group discussed objectives, timelines, and plans for implementation of these validation studies, as well as identifying new areas of research and disseminating results. The goal was to establish control as a valid concept that could help guide treatment decisions and motivate patients.
Child Health Working Group and Small Airways Study Group Joint MeetingZoe Mitchell
This document provides an agenda and background information for a meeting of the Small Airways & Child Health Working Group. The agenda includes discussions on ongoing publications regarding chest nomenclature and a systematic review on ICS particle size. Presentations will cover pre-school asthma wheeze, new ideas for the group focusing on implications of ICS particle size on GERD and ACOS, and an oscillometry study overview. Background information is provided on the chest commentary and systematic review, including results showing extra-fine ICS have higher odds of asthma control and lower exacerbation rates than fine particle ICS. A proposed study on pre-school asthma will compare outcomes of EF ICS to NEF ICS, LTRA,
A Quasi Experimental Study to Assess the Effectiveness of Selected Nursing In...iosrjce
A study to assess the effectiveness of selected nursing interventions on health related quality of life
and activities of daily living among COPD patients in selected tertiary hospital, Chennai, Tamilnadu, India.
The aim of the study was to impart the selected nursing interventions applied to the COPD patients in medical
and pulmonary wards. The conceptual framework used in this study was Widenbach’s Helping art Theory. An
Evaluative approach was used for the present study. Using purposive sampling technique 50 samples were
selected from Chettinad Hospital and Research Institute, Tamil Nadu, India. The tool used was self
administered questionnaire. The collected data was analyzed using descriptive and inferential statistics. The
findings of the study revealed a significantly increase in the COPD patients health related quality of life and
activities of daily living after given the selected nursing interventions. The mean pre test score was 1867 and
the mean post test score was 1861 and the difference between pre test and post test knowledge score was 5.54.
Based on the objectives of the study the findings of the level of health related quality of life and activities of
daily living among COPD patients shows that increased health related quality of life and activities of daily
living. The study shows that the COPD patients in post test were having post score1861 mean difference
5.54.standard deviation 2.35.p value (0.02). Selected nursing interventions are effective in increasing the health
related qualityof life and activities of daily living among COPD patients.. The findings of the study revealed that
a significantly increased in the post test health related quality of life and activities of daily living after given the
selected nursing interventions
The document summarizes a study evaluating the central line maintenance protocol at Baylor Scott & White Health. The protocol provides guidelines for cleaning, flushing, and dressing central lines. The study analyzes evidence from other research to determine if the protocol follows best practices. Several studies support aspects of the protocol like checklists, hub disinfection, and flushing guidelines. Overall, the evidence validates that the protocol is evidence-based. The recommendation is that Baylor Scott & White Health should continue adhering to their existing protocol to reduce central line infections.
The document summarizes a workshop on applying systems biology approaches to medical research and practice. The workshop aimed to analyze the current state, identify opportunities and barriers, and recommend areas for collaboration. Participants discussed how systems biology could help clinical trials, redefine disease phenotypes, discover biomarkers, enable combinatorial therapies, and improve drug development. Key areas for future research include understanding chronic diseases through network analysis, combining personalized omics data with clinical information, and developing combinatorial drug screening. The major challenge is for systems biology to help transition to a predictive, personalized, preventive and participatory model of medicine.
Small Airways Study Group Meeting 25/09/15Zoe Mitchell
The document outlines a planned study comparing the effectiveness of extra-fine particle inhaled corticosteroids (ICS) to non-extra fine ICS, leukotriene receptor antagonists (LTRAs), and short-acting beta agonists (SABAs) as step-up therapy options for preschool children with asthma or wheezing. The study will use data from UK primary care records to conduct a descriptive analysis of treatment patterns and a comparative effectiveness analysis over 1-year and exploratory 5-year outcome periods. The goal is to test if extra-fine ICS achieve better outcomes than alternatives as a step
1) A prospective multicenter study evaluated the use of thoracic ultrasound (TUS) to diagnose pulmonary embolism (PE) in 352 patients with clinically suspected PE.
2) TUS identified PE in 194 patients (55%), with CT pulmonary angiography used as the reference standard. TUS visualized more lung lesions than CT on average.
3) TUS criteria for diagnosing PE included seeing two or more typical subpleural triangular or rounded hypoechoic lesions, or one such lesion with a pleural effusion.
Large bowel obstruction -dr.p.saravanakumar ms pg tanjore medical collegeSaravanakumar Palanivel
This document discusses large bowel obstruction, including its classification, causes, pathogenesis, clinical features, investigations, and management. Large bowel obstruction can be classified depending on the nature, blood supply, presentation, and relation to the bowel lumen. The most common causes are colorectal cancer, colonic volvulus, and diverticulitis. Clinical features include abdominal distension, pain, constipation, and vomiting. Investigations include blood tests, imaging like CT, and endoscopy. Management involves resuscitation, decompression, surgery to resect non-viable bowel and anastomose or create a stoma, and treatment of underlying causes.
REG Adherence Working Group Meeting 26/09/15Zoe Mitchell
This document provides a summary of an upcoming meeting on asthma treatment adherence. The meeting will take place on September 26th in Amsterdam. It will be chaired by Eric van Ganse and focus on a bidirectional adherence study being conducted by an international research team. The study is analyzing the relationship between adherence to asthma treatment and asthma-related health outcomes using data from an electronic health records database. The agenda includes updates on the study design, measures of adherence and health outcomes, and initial analyses. Next steps for the study and opportunities to present preliminary findings are also discussed.
REG Technologies Working Group Meeting 26/09/15Zoe Mitchell
This document provides an agenda and notes from a meeting of the Technologies Working Group of the Respiratory Effectiveness Group (REG). The meeting objectives were to agree terms of reference for the group, discuss initial seed projects, and identify 1-2 longer term projects. Under terms of reference, the group will focus on technology-based solutions for chronic respiratory conditions, with a focus on monitoring and behavioral change. Initial seed project ideas discussed included evaluating practices for developing technology solutions, a literature review on using health information to change patient behavior, and optimizing technology interfaces for older patients. Preliminary data from a PhD student's survey of stakeholder attitudes towards smart inhalers was also presented. The group discussed potential future projects and grant opportunities.
REG IPF/ILD Working Group Meeting 25/09/15Zoe Mitchell
The document outlines plans for two diagnostic studies in interstitial lung disease (ILD). [1] Phase I will characterize ILD diagnostic practices globally, especially in underrepresented regions, to inform the design of [2] Phase II which will evaluate agreement and accuracy of ILD multidisciplinary team diagnoses across sites. The studies aim to establish best practice recommendations for optimizing the pathway to accurate ILD diagnosis.
This document summarizes a study that assessed current practices in teaching life support competencies in healthcare. The study conducted surveys to: 1) Identify life support courses provided in UK hospitals and required by professional bodies, 2) Describe curriculum content and teaching methods of popular in-hospital courses, 3) Examine fidelity of implementation of courses in England. The study found that most NHS hospitals provide adult life support courses, with the Resuscitation Council UK Advanced Life Support course most common. Many hospitals also provide in-house courses. Recognition and management of pre-arrest deterioration are now widely taught. While life support training is provided in all medical schools, approaches vary and pre-arrest management courses are less common. Only a
The meeting provided updates on current adherence projects and discussed ideas for future projects. For the current project on the bidirectional relationship between asthma outcomes and adherence, preliminary conclusions from Phase 2 were presented showing weak associations between adherence and control. Limitations were noted and next steps discussed. Two existing ideas for future studies using pharmacy and technology-based approaches were assessed for ongoing relevance, feasibility, validity and priority. New projects presented included a device optimization study and a project on age-related changes in childhood adherence and outcomes. Prioritization of adherence research needs and ensuring pursued priorities closed the discussion.
REG Interstitial Lung Disease Working Group MeetingZoe Mitchell
The meeting agenda included:
1) Introductions of working group members and REG supporters in attendance.
2) An overview of the Respiratory Effectiveness Group (REG) and its mission to conduct real-world respiratory research.
3) A discussion of potential research ideas led by Luca Richeldi, including characterizing healthcare utilization prior to ILD diagnosis, using electronic lung sounds for early diagnosis, and evaluating consistency of ILD diagnoses across multidisciplinary teams.
4) A final group discussion on other opportunities for collaboration within the ILD working group.
Inadequate management of asthma can lead to physical handicap and death. The study aimedto assess knowledge and practice of
asthmatic participants for use meter dose inhaler device. A descriptive study involved 105 participants, conducted at public
hospitals in Khartoum state from July to October2014. Questionnaire and observational check list were used for data collection.
The study enrolled (51%) female and (49%) male. Most of participants their age group ranged, between 36 to 45 years, (35%)
were workers and (31%) received University education while 44 % had a chronic asthma. Level of participant’s knowledge was a
very good regard care and storage of the device; sequent (77% - 79%). There were(64%) had moderate level of knowledge for
preparation dose (69%) replacing inhaler device and cleaning mouthpiece (60%), while 56% had very poor knowledge to rinse
mouth after puff. A highly significant difference between the level of knowledge and education (P value<0.001) regard replacing
the inhaler device, and cleansing mouthpiece. All participants demonstrated correct technique of using inhaler device, position,
removed, pressed replacement the cap, shaking inhaler device and took deep breath. While half of them had moderate skill level
for opened mouth technique, continuous breathing and rinsed mouth after puffuse, and fewer of participants had poor technique
during repeating the puff. Most of participants reflected moderate to poor level of knowledge and have very good practice for
correct used inhaler meter device; this reveals the discrepancy between knowledge and practice.
This document provides guidelines for evaluating patients with pulmonary nodules from the American College of Chest Physicians. It summarizes the guideline objectives, target population, diagnostic and management interventions considered, major outcomes, methodology, recommendations, and validation process. The guideline was developed through a systematic review of literature and expert consensus to provide evidence-based recommendations. It defines solitary pulmonary nodules and provides 12 major recommendations on pre-test probability assessment, imaging tests, PET scanning, discussion of risks/benefits with patients, and tissue diagnosis.
This document discusses maximizing patient outcomes in respiratory care. It outlines the founding principles of the Respiratory Effectiveness Group (REG), which aims to better integrate real-world evidence from sources like observational studies and pragmatic trials into clinical practice guidelines. Currently, guidelines are often based primarily on randomized controlled trials, which have limitations and may not generalize to most patients. The document calls for considering a diversity of evidence and tailoring care to individual patient needs and characteristics. It also discusses how databases could help achieve more personalized care by providing real-world data on topics like disease prevalence, treatments, and outcomes across different healthcare systems.
Severe Asthma/Biomarkers Working Group ERS 2017Kathryn Brown
The document summarizes a meeting of the Severe Asthma/Biomarkers Joint Working Group. It includes an agenda for presentations on recent and ongoing projects related to using biomarkers like FeNO and blood eosinophils to predict outcomes in severe asthma. Presentations covered recent publications on these topics, updates on registry initiatives like ISAR and available data sources like OPCRD, and ideas for new projects. Attendees also discussed previous ideas around further evaluating biomarkers as predictors of treatment response and clinical outcomes.
This document summarizes the agenda and key discussion points for several committee meetings taking place on September 26th in Amsterdam. The Research Review committee will discuss priorities for funding respiratory research studies in 2015/2016. They will also evaluate the process for soliciting and reviewing research ideas. The Accreditation committee will discuss accrediting researchers. The Manuscript Review committee will examine their publication process and output over the past year. Overall, the meetings aim to strategize how the organization can best support high-quality respiratory research through prioritizing ideas, funding studies, and disseminating results.
ATS Symposium: Leukotriene Antagonists As First-line Asthma Controller For St...Zoe Mitchell
ATS Symposium session presented by Prof. David Price:
Leukotriene Antagonists As First-line Asthma Controller For Step 2
Presented May 2015 at ATS 2015, Denver, Colorado, USA
This document summarizes the proceedings of the Small Airways Working Group Meeting held on September 9th, 2017 in Milan. It includes the agenda, list of attendees, and progress updates on several studies. Multiple studies comparing the effectiveness of extra-fine particle inhaled corticosteroids to fine particle ICS have been published or are underway. Preliminary results suggest extra-fine ICS may achieve better asthma control at lower doses and with fewer side effects like pneumonia. The group discussed potential future studies on flexible dosing strategies, metabolic effects of high dose ICS, and the impact of particle size in patients with obesity or GERD. Priority research areas and ongoing protocols were reviewed for continued relevance and feasibility.
REG COPD Control Working Group MeetingZoe Mitchell
1. The REG COPD Control Working Group met on May 17th in Denver, Colorado to discuss plans to validate the concept of control in COPD through several research studies.
2. These included a non-interventional database study using the UK OPCRD, two Spanish pilot studies on changes in control versus severity and symptoms, and an international prospective study to validate the concept of control.
3. The group discussed objectives, timelines, and plans for implementation of these validation studies, as well as identifying new areas of research and disseminating results. The goal was to establish control as a valid concept that could help guide treatment decisions and motivate patients.
Child Health Working Group and Small Airways Study Group Joint MeetingZoe Mitchell
This document provides an agenda and background information for a meeting of the Small Airways & Child Health Working Group. The agenda includes discussions on ongoing publications regarding chest nomenclature and a systematic review on ICS particle size. Presentations will cover pre-school asthma wheeze, new ideas for the group focusing on implications of ICS particle size on GERD and ACOS, and an oscillometry study overview. Background information is provided on the chest commentary and systematic review, including results showing extra-fine ICS have higher odds of asthma control and lower exacerbation rates than fine particle ICS. A proposed study on pre-school asthma will compare outcomes of EF ICS to NEF ICS, LTRA,
A Quasi Experimental Study to Assess the Effectiveness of Selected Nursing In...iosrjce
A study to assess the effectiveness of selected nursing interventions on health related quality of life
and activities of daily living among COPD patients in selected tertiary hospital, Chennai, Tamilnadu, India.
The aim of the study was to impart the selected nursing interventions applied to the COPD patients in medical
and pulmonary wards. The conceptual framework used in this study was Widenbach’s Helping art Theory. An
Evaluative approach was used for the present study. Using purposive sampling technique 50 samples were
selected from Chettinad Hospital and Research Institute, Tamil Nadu, India. The tool used was self
administered questionnaire. The collected data was analyzed using descriptive and inferential statistics. The
findings of the study revealed a significantly increase in the COPD patients health related quality of life and
activities of daily living after given the selected nursing interventions. The mean pre test score was 1867 and
the mean post test score was 1861 and the difference between pre test and post test knowledge score was 5.54.
Based on the objectives of the study the findings of the level of health related quality of life and activities of
daily living among COPD patients shows that increased health related quality of life and activities of daily
living. The study shows that the COPD patients in post test were having post score1861 mean difference
5.54.standard deviation 2.35.p value (0.02). Selected nursing interventions are effective in increasing the health
related qualityof life and activities of daily living among COPD patients.. The findings of the study revealed that
a significantly increased in the post test health related quality of life and activities of daily living after given the
selected nursing interventions
The document summarizes a study evaluating the central line maintenance protocol at Baylor Scott & White Health. The protocol provides guidelines for cleaning, flushing, and dressing central lines. The study analyzes evidence from other research to determine if the protocol follows best practices. Several studies support aspects of the protocol like checklists, hub disinfection, and flushing guidelines. Overall, the evidence validates that the protocol is evidence-based. The recommendation is that Baylor Scott & White Health should continue adhering to their existing protocol to reduce central line infections.
The document summarizes a workshop on applying systems biology approaches to medical research and practice. The workshop aimed to analyze the current state, identify opportunities and barriers, and recommend areas for collaboration. Participants discussed how systems biology could help clinical trials, redefine disease phenotypes, discover biomarkers, enable combinatorial therapies, and improve drug development. Key areas for future research include understanding chronic diseases through network analysis, combining personalized omics data with clinical information, and developing combinatorial drug screening. The major challenge is for systems biology to help transition to a predictive, personalized, preventive and participatory model of medicine.
Small Airways Study Group Meeting 25/09/15Zoe Mitchell
The document outlines a planned study comparing the effectiveness of extra-fine particle inhaled corticosteroids (ICS) to non-extra fine ICS, leukotriene receptor antagonists (LTRAs), and short-acting beta agonists (SABAs) as step-up therapy options for preschool children with asthma or wheezing. The study will use data from UK primary care records to conduct a descriptive analysis of treatment patterns and a comparative effectiveness analysis over 1-year and exploratory 5-year outcome periods. The goal is to test if extra-fine ICS achieve better outcomes than alternatives as a step
1) A prospective multicenter study evaluated the use of thoracic ultrasound (TUS) to diagnose pulmonary embolism (PE) in 352 patients with clinically suspected PE.
2) TUS identified PE in 194 patients (55%), with CT pulmonary angiography used as the reference standard. TUS visualized more lung lesions than CT on average.
3) TUS criteria for diagnosing PE included seeing two or more typical subpleural triangular or rounded hypoechoic lesions, or one such lesion with a pleural effusion.
Large bowel obstruction -dr.p.saravanakumar ms pg tanjore medical collegeSaravanakumar Palanivel
This document discusses large bowel obstruction, including its classification, causes, pathogenesis, clinical features, investigations, and management. Large bowel obstruction can be classified depending on the nature, blood supply, presentation, and relation to the bowel lumen. The most common causes are colorectal cancer, colonic volvulus, and diverticulitis. Clinical features include abdominal distension, pain, constipation, and vomiting. Investigations include blood tests, imaging like CT, and endoscopy. Management involves resuscitation, decompression, surgery to resect non-viable bowel and anastomose or create a stoma, and treatment of underlying causes.
Este documento presenta los resultados de un estudio retrospectivo sobre la sensibilidad y especificidad del ultrasonido FAST (focused assessment with sonography for trauma) para detectar líquido libre en pacientes con trauma abdominal. El estudio analizó 405 ultrasonidos FAST realizados entre 2004 y 2005, encontrando una sensibilidad del 100% y una especificidad del 97.78%. Diez casos clínicos ilustran hallazgos positivos en ultrasonido FAST confirmados posteriormente por tomografía computarizada.
Renal inflammatory diseases of the kidney Part 2 discusses various inflammatory conditions that affect the kidneys including xanthogranulomatous pyelonephritis, renal tuberculosis, fungal infections, post-radiation injury, and renal malakoplakia. Imaging findings for each condition are provided with CT, ultrasound, and radiograph examples. The document describes the pathophysiology, clinical presentation, and characteristic imaging appearance for each disease to aid radiologists in diagnosis.
Este documento describe la utilidad de la ecografía de tórax para el diagnóstico de patologías respiratorias en pacientes críticos. Explica que la ecografía es una herramienta económica y no invasiva que puede detectar con alta sensibilidad y especificidad derrame pleural, neumotórax y neumonía. También discute el potencial pero aún limitado papel de la ecografía para diagnosticar tromboembolismo pulmonar. Concluye que la ecografía de tórax es útil para el enfoque inicial
Tubulointerstitial nephritis involves inflammatory reactions in the renal tubules and interstitium. It can be primary, secondary to other renal diseases, idiopathic, reactive to infections, or infectious itself. Acute tubular necrosis is characterized by tubular epithelial cell death due to ischemia or toxins and can cause acute kidney injury. Chronic tubulointerstitial nephritis develops over months or years and is associated with progressive loss of kidney function. It has many etiologies including drugs, infections, obstructive nephropathy, and autoimmune diseases.
Ultrasound is a useful screening tool for the lungs but has limitations. An 8-view ultrasound exam of the lungs can detect extravascular lung water seen as B lines originating from the pleural line. While a normal exam has evenly spaced A lines, more than 2 B lines in any view outside the lung bases indicates abnormality. Ultrasound has good sensitivity and specificity for detecting diffuse lung abnormalities compared to chest x-ray, but can miss localized findings and has a 15% error rate in certain conditions like fibrosis or resolving illnesses.
Eco fast y tac en trauma cerrado de abdomenJose Diaz
Este documento resume las guías para el uso del ultrasonido abdominal rápido (ECO FAST) y la tomografía computarizada (TAC) abdominal en la evaluación de pacientes con trauma cerrado abdominal. El ECO FAST puede detectar líquido libre pero no descarta completamente lesiones internas. Un ECO FAST negativo requiere control en 6-12 horas o una TAC si el paciente está hemodinámicamente estable. La TAC proporciona mayor detalle sobre lesiones sólidas y huecas pero requiere estabilidad hemodinámica y no está disponible las 24
El documento describe el examen FAST (Focused Assessment with Sonography in Trauma) y E-FAST. FAST evalúa la presencia de líquido libre en la cavidad abdominal mediante ultrasonido en menos de 3 minutos. E-FAST amplía la evaluación a la pared torácica para diagnosticar neumotórax y derrame pleural. Estudios muestran que FAST tiene alta sensibilidad y especificidad para detectar hemoperitoneo y es útil para la toma de decisiones quirúrgicas en trauma toracoabdominal.
Without a complete published description of interventions, clinicians and
patients cannot reliably implement interventions that are shown to be
useful, and other researchers cannot replicate or build on research
findings. The quality of description of interventions in publications,
however, is remarkably poor. To improve the completeness of reporting,
and ultimately the replicability, of interventions, an international group
of experts and stakeholders developed the Template for Intervention
Description and Replication (TIDieR) checklist and guide. The process
involved a literature review for relevant checklists and research, a Delphi
survey of an international panel of experts to guide item selection, and
a face to face panel meeting. The resultant 12 item TIDieR checklist
(brief name, why, what (materials), what (procedure), who provided,
how, where, when and how much, tailoring, modifications, how well
(planned), how well (actual)) is an extension of the CONSORT 2010
statement (item 5) and the SPIRIT 2013 statement (item 11). While the
emphasis of the checklist is on trials, the guidance is intended to apply
across all evaluative study designs. This paper presents the TIDieR
checklist and guide, with an explanation and elaboration for each item,
and examples of good reporting. The TIDieR checklist and guide should
improve the reporting of interventions and make it easier for authors to
structure accounts of their interventions, reviewers and editors to assess
the descriptions, and readers to use the information.
Guidelines for the management of hospital-adquired pneumonia ERJ 2017.pdfDenisBacinschi2
This document provides guidelines from the European Respiratory Society (ERS) and other groups for the management of hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP). It summarizes recent studies on the epidemiology, diagnosis, treatment and prevention of HAP/VAP. An international panel of experts was convened to develop evidence-based recommendations using the GRADE methodology. The resulting guidelines address the diagnosis, treatment and prevention of HAP/VAP to improve patient outcomes and reduce healthcare costs.
The document summarizes guidelines from a consensus conference on the diagnosis and treatment of acute appendicitis (AA). Regarding diagnostic efficiency of clinical scoring systems:
- Several scoring systems have been developed to predict AA based on history, exam, and labs, including the Alvarado score and Appendicitis Inflammatory Response (AIR) score.
- The Alvarado score has been most extensively studied but performance depends on cutoff; an AIR score below 4 or above 8 can help rule out or rule in AA.
- Scoring systems can help structure management but none is sufficiently accurate alone to rule in or out surgery.
Ομιλία-Παρουσίαση: Edith Frénoy, Director of Market Access/HTA, European Federation of Pharmaceutical Industries Associations (EFPIA)
Τίτλος Ομιλίας: «HTA cooperation in Europe: can it support the Greek debate?»
This document summarizes the results of a survey assessing compliance with 2013 European trauma guidelines across trauma centers in Europe. The survey received 296 responses from trauma providers, 243 from European countries. It found significant heterogeneity across centers in clinical protocols for trauma patients. Compliance with guidelines was frequently lacking, including blood pressure and fluid resuscitation targets. Only about a third complied with recommended blood pressure targets for patients with and without traumatic brain injury. Crystalloids were predominant for fluid resuscitation but vasopressor use was also common. Further efforts are needed to improve implementation of consensus guidelines across Europe.
This document provides a summary of the Respiratory Effectiveness Group (REG) Collaborators' Meeting held at the 2013 European Respiratory Society Congress in Barcelona. The meeting agenda included updates on current REG activities like publications, research studies, and quality standards. Presentations were given on new data from studies on asthma and COPD phenotypes, smoking cessation, and validating real-life asthma endpoints. There was also discussion of developing standards for real-life research, engaging with guidelines, and new initiatives from collaborators. The research update highlighted studies on asthma control and adherence, oral steroid burden in refractory asthma, and predicting asthma risk.
The document discusses a seminar on assessing eHealth and telemedicine services with a focus on patient outcomes and involvement. It describes several frameworks for assessment, including MAST, a multidimensional framework adopted in several European countries. MAST suggests a three stage assessment process including pre-assessment, multidisciplinary assessment of domains like clinical effectiveness and patient perspective, and assessing transferability. Effective involvement of patients is highlighted, noting they can provide information on outcomes and expectations through methods like interviews, questionnaires and diaries. Their views are influenced by factors like comfort with technology and interaction with professionals.
The document discusses the International Council for Harmonisation (ICH), a joint regulatory initiative between Europe, Japan, and the United States to harmonize technical requirements for pharmaceutical product registration. The ICH seeks to streamline development and review processes, reduce unnecessary testing on humans and animals, and ensure safety, quality and efficacy globally. Key topics covered include ICH objectives and members, guidelines produced on quality, safety, efficacy and multidisciplinary issues, and the process for harmonizing requirements.
This document provides guidelines for indoor air quality related to dampness and mould. When sufficient moisture is available, hundreds of species of bacteria and fungi grow indoors, particularly mould. Exposure to these pollutants increases respiratory symptoms, allergies, asthma, and impacts the immune system. The most important way to avoid health effects is preventing persistent dampness and microbial growth on indoor surfaces. The guidelines provide an overview of health problems from this pollution and measures to control mould growth indoors.
1.5 international conference on harmonizationShital Patil
ICH is a joint initiative involving both regulators and research-based industry representatives of the EU, Japan and the US in scientific and technical discussions of the testing procedures required to assess and ensure the safety, quality and efficacy of medicines.
Professor Cindy Farquhar
Cochrane Menstrual Disorders & Subfertility Group
NZ Cochrane Branch of the Australasian Cochrane Centre
New Zealand Guidelines Group
National Women’s Health
University of Auckland
The document summarizes the Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain (CNCP). It was developed by the National Opioid Use Guideline Group (NOUGG) in response to the lack of national guidelines on opioid use for CNCP and growing concerns about opioid misuse. NOUGG aimed to develop an evidence-based national guideline to assist physicians in safely and effectively prescribing opioids for CNCP patients. Key activities included establishing an expert panel, conducting a literature review, consulting medical regulators, and developing plans for ongoing evaluation and updates to help transition the guidelines into practice.
1) Anaesthesiology has a key role in patient safety for surgical procedures and other vulnerable situations. Around 230 million patients undergo anaesthesia yearly, with 7 million developing complications and 1 million dying.
2) Leaders in anaesthesiology societies agree that patients have a right to safe care. Key goals include endorsing international safety standards, educating patients, providing appropriate resources, improving education, and developing safe drugs and equipment.
3) Specific aims are that all institutions providing anaesthesia comply with monitoring standards, have safety protocols, comply with sedation standards, support the WHO checklist, collect safety data, and contribute to audits and reporting.
The document discusses evidence-based healthcare and the role of the Cochrane Collaboration. It describes how the Cochrane Collaboration conducts systematic reviews of healthcare interventions to help people make informed healthcare decisions. It has over 15,000 contributors globally who produce reviews and summaries to reduce bias and provide reliable information to healthcare providers, policymakers, and the public. The Collaboration aims to bridge the gap between research evidence and practice through disseminating its findings widely.
Exposure to outdoor air pollution and its human.pptxdipakghimire77
This scoping review examined the relationship between outdoor air pollution and health outcomes. 799 studies were included. The studies showed an increasing trend from 1992 to 2008 and were primarily conducted in Asia, Europe, and North America. Asthma and mortality were the most commonly studied health outcomes. 95.2% of studies reported statistically positive associations between air pollution and adverse health effects. The review identified gaps in research on certain population groups and health outcomes to guide future studies.
Exposure to outdoor air pollution and its effect.pptxdipakghimire77
Outdoor air pollution is a complex and pervasive environmental issue that affects millions of people worldwide. The continuous release of pollutants into the atmosphere from various sources has led to widespread exposure, contributing to a range of health problems. This comprehensive review explores the sources, composition, and health effects of outdoor air pollution, emphasizing the significance of addressing this global challenge.
This document provides an overview of the ICH S11 guideline for non-clinical safety testing to support development of pediatric medicines. The guideline recommends standards for determining when juvenile animal testing provides informative data to support pediatric clinical trials. It advises that such testing should be considered when previous animal and human safety data, including from other drugs in the same class, are deemed sufficient to back pediatric studies. The expert working group developing the guideline will include representatives from regulatory bodies and the pharmaceutical industry across key regions.
This document provides guidelines on the diagnosis and management of syncope. It defines syncope and provides a brief overview of the pathophysiology. The document is divided into four parts: classification, epidemiology and prognosis; diagnosis; treatment; and special issues in evaluating patients with syncope. The guidelines aim to provide recommendations on diagnostic criteria, diagnostic workup, risk stratification, and determining when hospitalization is needed. Most recommendations are based on consensus expert opinion due to the lack of randomized controlled trials in this area.
This document summarizes the structure and process for developing ESMO (European Society for Medical Oncology) clinical practice guidelines. It describes how ESMO guidelines are created through an editorial board and author/reviewer process, or through consensus conferences involving multidisciplinary experts. The consensus conference process involves a pre-conference working group reviewing evidence, a 2-day conference to discuss recommendations, and post-conference finalization. ESMO guidelines are published annually in Annals of Oncology and translated into multiple languages to disseminate best practices for cancer treatment.
Should functional mr be fixed in heart failuredrucsamal
This document discusses functional mitral regurgitation (FMR) in heart failure patients. It presents evidence that even mild FMR results in poor survival outcomes, and that FMR is not just a late marker but also a cause of worse prognosis. Surgical mitral repair using a small, complete, rigid ring to reduce the mitral annulus has been shown to improve survival, ventricular remodeling, and functional status compared to no repair or incomplete repairs that do not fully correct FMR. Ongoing studies are exploring newer percutaneous approaches to treating FMR, but surgical repair remains the standard treatment when anatomically feasible to fully correct FMR.
Aortic Valve Stenosis with low EF : TAVR versus Replacementdrucsamal
1) Patients with low ejection fraction (EF < 50%) and severe aortic stenosis who undergo transcatheter aortic valve replacement (TAVI) have similar mortality at 1 year compared to those with higher EF, despite being higher risk.
2) TAVI is associated with significant improvements in EF, symptoms, and quality of life over 1 year in patients with very low EF (≤30%). However, mortality remains higher compared to those with EF >30%.
3) Both TAVI and surgical aortic valve replacement (SAVR) are associated with improvements in EF at 3 months in propensity matched populations with low EF. Short term outcomes are similar, but TAVI is associated with more pacemakers
When is less more minimally invasive surgery in low efdrucsamal
The document discusses treatment options for patients with reduced ejection fraction and secondary mitral regurgitation, including the use of minimally invasive mitral valve surgery which can be considered for elderly patients or those with comorbidities. It presents a case study of a 69-year-old male with severe secondary mitral regurgitation who underwent a minimally invasive mitral valve repair which eliminated his mitral regurgitation and improved his symptoms and ejection fraction. Long-term data on isolated mitral valve surgery in patients with reduced ejection fraction shows improvement in mitral regurgitation and functional status with no difference in survival between repair and replacement
The document discusses when to consider tricuspid valve repair. Tricuspid regurgitation is associated with poor prognosis, especially when secondary to left-sided heart lesions, cardiomyopathy, pulmonary hypertension, or in the setting of LVAD placement or heart transplantation. Tricuspid valve repair is indicated for severe, symptomatic primary tricuspid regurgitation, and may also be considered for significant functional regurgitation concurrent with mitral valve surgery, after isolated mitral valve surgery if regurgitation is severe, or when placing a continuous-flow LVAD. Prophylactic tricuspid annuloplasty during heart transplantation reduces the severity of post-operative regurgitation and is associated with improved long-term survival
Cad and low ef does viability assessment matterdrucsamal
This document discusses the value of viability studies in patients with coronary artery disease (CAD) and low ejection fraction (EF). It summarizes several studies on the topic and discusses their limitations. A key trial was the STICH trial, which found no significant difference in outcomes between revascularization and medical therapy alone, challenging the belief that revascularization benefits those with viable myocardium. The document concludes that while viability concepts are biologically plausible, recent trials create confusion and there is no consensus on how to apply viability testing in practice.
This document discusses the conundrum of managing mitral regurgitation (MR) in patients with heart failure. It highlights the importance of using multimodality imaging to:
1) Assess the severity of MR at rest and with exercise to determine risk and need for intervention.
2) Evaluate left ventricular function, dyssynchrony, viability and ischemia to determine indications for cardiac resynchronization therapy or revascularization.
3) Assess left ventricular remodeling and mitral valve deformation to predict risk of recurrent MR after repair and determine the best repair/replacement option.
Imaging provides essential information to optimize treatment strategies for MR in heart failure.
The complex patient vad transplant exchange or hospicedrucsamal
This document discusses the case of a 76-year-old man presenting with heart failure symptoms and recurrent cough syncope. Testing revealed cardiac amyloidosis due to a TTR gene mutation. For patients with TTR amyloidosis, treatment options include organ transplantation, TTR stabilizers in clinical trials, or enrollment in hospice. Given his age and comorbidities, the man's options included a left ventricular assist device, extended criteria transplant, or a clinical trial for TTR amyloidosis treatment. He was ultimately listed and transplanted, and has since recovered well.
The complex patient vad transplant exchange or hospicedrucsamal
This document discusses the case of a 76-year-old man presenting with heart failure symptoms and recurrent cough syncope. Testing revealed cardiac amyloidosis due to a TTR gene mutation. For patients with TTR amyloidosis, treatment options include organ transplantation, TTR stabilizers in clinical trials, or enrollment in hospice. Given his age and comorbidities, the man's options included a left ventricular assist device, extended criteria transplant, or a clinical trial for TTR amyloidosis treatment. He was ultimately listed and transplanted within a month, and has since recovered well.
Surgical director heart transplant and mechanical assist device programdrucsamal
The document discusses a 55-year-old female patient with a history of rheumatic valve disease and multiple prior heart surgeries who was admitted with recurrent heart failure and an ejection fraction below 10%, outlining her medical history and current status, treatment options, and clinical course including optimization, a redo aortic valve replacement and implantation of a HeartMate II left ventricular assist device.
The complex patient vad ransplant vad exchange or hospicedrucsamal
L.B. is a 62-year-old man with a long history of coronary artery disease and heart failure who has undergone multiple coronary bypass surgeries. He now has an ejection fraction of 25% and intractable ventricular tachycardia despite medical management. Due to the risks of ablation, the team is considering options like hospice care, cardiac transplantation, VAD implantation, or VAD exchange to treat his advanced heart failure. A cardiac catheterization revealed multiple occluded arteries and stenoses. Given his medical history and surgical history, the team must determine the best treatment approach for his condition.
This document discusses the management of mitral regurgitation (MR) in heart failure patients. It explores the differences between primary and functional (secondary) MR, and notes that correcting primary MR may improve outcomes but the benefits are less clear for functional MR which is primarily a ventricular problem. The document reviews potential management options for MR in heart failure including optimal medical therapy, cardiac resynchronization therapy, surgery, and percutaneous techniques such as the MitraClip system. It presents evidence from studies on the acute effects of CRT and the impact of CRT on functional MR severity. It also discusses guidelines on indications for mitral valve surgery in chronic secondary MR and barriers to surgery.
Whom to refer for mitral valve repair and whom notdrucsamal
This document discusses the treatment of mitral regurgitation in patients with heart failure. It describes the mechanisms of functional and ischemic mitral regurgitation. While medical therapy can improve symptoms and survival, cardiac resynchronization therapy may also help reduce mitral regurgitation severity and improve outcomes. Surgery to repair the mitral valve is an option but the risk of recurrence of mitral regurgitation is high, especially with more advanced left ventricular remodeling. Randomized trials are still needed to determine whether surgical correction provides clear benefits over medical therapy alone in high-risk patients. Percutaneous mitral valve repair may be a lower risk option for inoperable patients to reduce symptoms.
Devices and intervention in heart failure.drucsamal
- The document discusses the speaker's receipt of honoraria and research support from numerous pharmaceutical and device companies.
- It summarizes several journal articles and studies related to left ventricular remodeling post-myocardial infarction, baroreflex activation therapy for heart failure, and the effects of bi-ventricular pacing on left ventricular ejection fraction and end-systolic volume.
- Key findings from the PACE trial are highlighted showing improvements in left ventricular ejection fraction and end-systolic volume up to 2 years with bi-ventricular pacing compared to right ventricular pacing alone.
European Journal of Heart Failure's year in Cardiologydrucsamal
This document contains information about Prof. Fausto J. Pinto who is the Head of Cardiology at University Hospital Sta Maria-HPV and University of Lisbon in Portugal. It discloses that he has received consultancy fees and lecture fees from various pharmaceutical companies. It also contains several figures and images from various medical studies and publications related to cardiology.
This document lists the collaborations and conflicts of interest for speakers Thomas F. Lüscher and Marco Metra. It notes that they have received research grants, educational grants, and honoraria from numerous pharmaceutical companies. The rest of the document discusses the European Heart Journal, including new associate editors, submission rates and acceptance rates, impact factors, and plans to launch new open access and supplement journals.
This document summarizes a presentation on cardiology topics including acute and advanced heart failure. It discusses trends in heart failure hospitalizations and mortality. It describes different hemodynamic profiles in acute heart failure patients and their corresponding treatments. It also discusses topics like iron deficiency in heart failure, sleep disordered breathing, and a study showing sleep disordered breathing is common in acute heart failure and predicts mortality.
This document discusses the importance of prevention in treating cardiovascular disease. It outlines stages of heart failure progression from asymptomatic left ventricular dysfunction to refractory heart failure. Clinical trials show benefits of treating hypertension and post-MI left ventricular dysfunction to prevent heart failure. Treatment with ACE inhibitors reduces mortality and morbidity from heart failure. Prevention of risk factors is emphasized as the best strategy to avoid full-blown heart disease.
Can we afford heart failure management in the futuredrucsamal
Heart failure is a major global health problem, affecting 26 million people worldwide. It accounts for 1-3% of hospital admissions in Europe and North America. Hospitalization is the main driver of the high economic costs of heart failure management, which is estimated to rise significantly in the coming decade. To better manage heart failure costs in the future, new models of coordinated and integrated care will need to be implemented, with a focus on preventing hospitalizations and readmissions through improved education, care transitions, and treatment of comorbidities.
This document discusses statistics related to heart failure. It summarizes data on outcomes for hospitalized heart failure patients compared to chronic heart failure patients. Hospitalized patients generally have worse outcomes, with high 1-year mortality rates around 25-27%. Chronic heart failure patients have lower but still significant 1-year mortality rates of around 5-6%. The document also reviews real-world data showing high readmission rates after hospitalization for heart failure. It concludes that while treatments for chronic heart failure with reduced ejection fraction have improved outcomes over decades, more efforts are still needed to improve care and outcomes for hospitalized patients and those with preserved ejection fraction.
The heart failure association global awareness programme.drucsamal
The Global Heart Failure Awareness Programme aims to make the prevention and management of heart failure a global health priority. It is led by the Heart Failure Association of the European Society of Cardiology and supported by educational grants. The programme's objectives are to build a common global approach to raising awareness of heart failure among targeted audiences and to call for heart failure to be a health priority in every country. It plans to achieve this through developing educational content, building advocacy coalitions, and implementing initiatives at the national and local levels between 2015 and 2017.
International Cancer Survivors Day is celebrated during June, placing the spotlight not only on cancer survivors, but also their caregivers.
CANSA has compiled a list of tips and guidelines of support:
https://cansa.org.za/who-cares-for-cancer-patients-caregivers/
Chandrima Spa Ajman is one of the leading Massage Center in Ajman, which is open 24 hours exclusively for men. Being one of the most affordable Spa in Ajman, we offer Body to Body massage, Kerala Massage, Malayali Massage, Indian Massage, Pakistani Massage Russian massage, Thai massage, Swedish massage, Hot Stone Massage, Deep Tissue Massage, and many more. Indulge in the ultimate massage experience and book your appointment today. We are confident that you will leave our Massage spa feeling refreshed, rejuvenated, and ready to take on the world.
Visit : https://massagespaajman.com/
Call : 052 987 1315
Michigan HealthTech Market Map 2024. Includes 7 categories: Policy Makers, Academic Innovation Centers, Digital Health Providers, Healthcare Providers, Payers / Insurance, Device Companies, Life Science Companies, Innovation Accelerators. Developed by the Michigan-Israel Business Accelerator
Joker Wigs has been a one-stop-shop for hair products for over 26 years. We provide high-quality hair wigs, hair extensions, hair toppers, hair patch, and more for both men and women.
Let's Talk About It: Breast Cancer (What is Mindset and Does it Really Matter?)bkling
Your mindset is the way you make sense of the world around you. This lens influences the way you think, the way you feel, and how you might behave in certain situations. Let's talk about mindset myths that can get us into trouble and ways to cultivate a mindset to support your cancer survivorship in authentic ways. Let’s Talk About It!
The facial nerve, also known as cranial nerve VII, is one of the 12 cranial nerves originating from the brain. It's a mixed nerve, meaning it contains both sensory and motor fibres, and it plays a crucial role in controlling various facial muscles, as well as conveying sensory information from the taste buds on the anterior two-thirds of the tongue.
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...rightmanforbloodline
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
This particular slides consist of- what is hypotension,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is the summary of hypotension:
Hypotension, or low blood pressure, is when the pressure of blood circulating in the body is lower than normal or expected. It's only a problem if it negatively impacts the body and causes symptoms. Normal blood pressure is usually between 90/60 mmHg and 120/80 mmHg, but pressures below 90/60 are generally considered hypotensive.
The best massage spa Ajman is Chandrima Spa Ajman, which was founded in 2023 and is exclusively for men 24 hours a day. As of right now, our parent firm has been providing massage services to over 50,000+ clients in Ajman for the past 10 years. It has about 8+ branches. This demonstrates that Chandrima Spa Ajman is among the most reasonably priced spas in Ajman and the ideal place to unwind and rejuvenate. We provide a wide range of Spa massage treatments, including Indian, Pakistani, Kerala, Malayali, and body-to-body massages. Numerous massage techniques are available, including deep tissue, Swedish, Thai, Russian, and hot stone massages. Our massage therapists produce genuinely unique treatments that generate a revitalized sense of inner serenely by fusing modern techniques, the cleanest natural substances, and traditional holistic therapists.
Hypertension and it's role of physiotherapy in it.Vishal kr Thakur
This particular slides consist of- what is hypertension,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is summary of hypertension -
Hypertension, also known as high blood pressure, is a serious medical condition that occurs when blood pressure in the body's arteries is consistently too high. Blood pressure is the force of blood pushing against the walls of blood vessels as the heart pumps it. Hypertension can increase the risk of heart disease, brain disease, kidney disease, and premature death.
Healthy Eating Habits:
Understanding Nutrition Labels: Teaches how to read and interpret food labels, focusing on serving sizes, calorie intake, and nutrients to limit or include.
Tips for Healthy Eating: Offers practical advice such as incorporating a variety of foods, practicing moderation, staying hydrated, and eating mindfully.
Benefits of Regular Exercise:
Physical Benefits: Discusses how exercise aids in weight management, muscle and bone health, cardiovascular health, and flexibility.
Mental Benefits: Explains the psychological advantages, including stress reduction, improved mood, and better sleep.
Tips for Staying Active:
Encourages consistency, variety in exercises, setting realistic goals, and finding enjoyable activities to maintain motivation.
Maintaining a Balanced Lifestyle:
Integrating Nutrition and Exercise: Suggests meal planning and incorporating physical activity into daily routines.
Monitoring Progress: Recommends tracking food intake and exercise, regular health check-ups, and provides tips for achieving balance, such as getting sufficient sleep, managing stress, and staying socially active.
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...nirahealhty
The South Beach Coffee Java Diet is a variation of the popular South Beach Diet, which was developed by cardiologist Dr. Arthur Agatston. The original South Beach Diet focuses on consuming lean proteins, healthy fats, and low-glycemic index carbohydrates. The South Beach Coffee Java Diet adds the element of coffee, specifically caffeine, to enhance weight loss and improve energy levels.
Comprehensive Rainy Season Advisory: Safety and Preparedness Tips.pdfDr Rachana Gujar
The "Comprehensive Rainy Season Advisory: Safety and Preparedness Tips" offers essential guidance for navigating rainy weather conditions. It covers strategies for staying safe during storms, flood prevention measures, and advice on preparing for inclement weather. This advisory aims to ensure individuals are equipped with the knowledge and resources to handle the challenges of the rainy season effectively, emphasizing safety, preparedness, and resilience.
2024 HIPAA Compliance Training Guide to the Compliance OfficersConference Panel
Join us for a comprehensive 90-minute lesson designed specifically for Compliance Officers and Practice/Business Managers. This 2024 HIPAA Training session will guide you through the critical steps needed to ensure your practice is fully prepared for upcoming audits. Key updates and significant changes under the Omnibus Rule will be covered, along with the latest applicable updates for 2024.
Key Areas Covered:
Texting and Email Communication: Understand the compliance requirements for electronic communication.
Encryption Standards: Learn what is necessary and what is overhyped.
Medical Messaging and Voice Data: Ensure secure handling of sensitive information.
IT Risk Factors: Identify and mitigate risks related to your IT infrastructure.
Why Attend:
Expert Instructor: Brian Tuttle, with over 20 years in Health IT and Compliance Consulting, brings invaluable experience and knowledge, including insights from over 1000 risk assessments and direct dealings with Office of Civil Rights HIPAA auditors.
Actionable Insights: Receive practical advice on preparing for audits and avoiding common mistakes.
Clarity on Compliance: Clear up misconceptions and understand the reality of HIPAA regulations.
Ensure your compliance strategy is up-to-date and effective. Enroll now and be prepared for the 2024 HIPAA audits.
Enroll Now to secure your spot in this crucial training session and ensure your HIPAA compliance is robust and audit-ready.
https://conferencepanel.com/conference/hipaa-training-for-the-compliance-officer-2024-updates
2024 HIPAA Compliance Training Guide to the Compliance Officers
Point of Care Lung Ultrasound
1. Giovanni Volpicelli
Mahmoud Elbarbary
Michael Blaivas
Daniel A. Lichtenstein
Gebhard Mathis
Andrew W. Kirkpatrick
Lawrence Melniker
Luna Gargani
Vicki E. Noble
Gabriele Via
Anthony Dean
James W. Tsung
Gino Soldati
Roberto Copetti
Belaid Bouhemad
Angelika Reissig
Eustachio Agricola
Jean-Jacques Rouby
Charlotte Arbelot
Andrew Liteplo
Ashot Sargsyan
Fernando Silva
Richard Hoppmann
Raoul Breitkreutz
Armin Seibel
Luca Neri
Enrico Storti
Tomislav Petrovic
International Liaison Committee on Lung Ultrasound
(ILC-LUS) for the International
Consensus Conference on Lung Ultrasound (ICC-LUS)
International evidence-based
recommendations for point-of-care
lung ultrasound
Received: 29 October 2011
Accepted: 23 January 2012
Published online: 6 March 2012
Ó Copyright jointly held by Springer and
ESICM 2012
Electronic supplementary material
The online version of this article
(doi:10.1007/s00134-012-2513-4) contains
supplementary material, which is available
to authorized users.
G. Volpicelli ())
Department of Emergency Medicine,
San Luigi Gonzaga University Hospital,
10043 Orbassano, Torino, Italy
e-mail: gio.volpicelli@tin.it
M. Elbarbary
National & Gulf Center for Evidence Based
Health Practice, King Saud University for
Health Sciences, Riyadh, Saudi Arabia
e-mail: mahmoud_barbary@yahoo.com
M. Blaivas
Department of Emergency Medicine,
Northside Hospital Forsyth,
Atlanta, GA, USA
e-mail: mike@blaivas.org
D. A. Lichtenstein
Service de Re´animation Me´dicale, Hoˆpital
Ambroise-Pare´, Paris-Ouest, Boulogne,
France
e-mail: dlicht@free.fr
G. Mathis
Internal Medicine Praxis, Rankweil, Austria
e-mail: gebhard.mathis@cable.vol.at
A. W. Kirkpatrick
Foothills Medical Centre, Calgary, AB,
Canada
e-mail: andrew.kirkpatrick@
albertahealthservices.ca
L. Melniker
Clinical Epidemiology Unit, Division of
General Internal Medicine, Department
of Medicine, Weill Medical College of
Cornell University, New York, USA
e-mail: lawrence.melniker@winfocus.org
L. Gargani
Institute of Clinical Physiology,
National Research Council, Pisa, Italy
e-mail: gargani@ifc.cnr.it
V. E. Noble
Division of Emergency Ultrasound,
Department of Emergency Medicine,
Massachusetts General Hospital,
Boston, MA, USA
e-mail: vnoble@partners.org
G. Via
1st Department of Anesthesia and Intensive
Care Pavia, IRCCS Foundation Policlinico
San Matteo, Pavia, Italy
e-mail: gabriele.via@winfocus.org
Intensive Care Med (2012) 38:577–591
DOI 10.1007/s00134-012-2513-4 CONFERENCE REPORTS AND EXPERT PANEL
2. A. Dean
Division of Emergency Ultrasonography,
Department of Emergency Medicine,
University of Pennsylvania Medical Center,
Philadelphia, PA, USA
e-mail: anthony.dean@uphs.upenn.edu
J. W. Tsung
Departments of Emergency Medicine and
Pediatrics, Mount Sinai School of Medicine,
New York, NY, USA
e-mail: jtsung@gmail.com
G. Soldati
Emergency Medicine Unit, Valle del
Serchio General Hospital, Lucca, Italy
e-mail: g.soldati@usl2.toscana.it
R. Copetti
Medical Department, Latisana Hospital,
Udine, Italy
e-mail: robcopet@tin.it
B. Bouhemad
Surgical Intensive Care Unit, Department
of Anesthesia and Critical Care, Groupe
Hospitalier Paris Saint-Joseph, Paris, France
e-mail: belaid_bouhemad@hotmail.com
A. Reissig
Department of Pneumology and
Allergology, Medical University Clinic I,
Friedrich-Schiller University,
Jena, Germany
e-mail: Angelika.Reissig@med.uni-jena.de
E. Agricola
Division of Noninvasive Cardiology,
San Raffaele Scientific Institute, IRCCS,
Milan, Italy
e-mail: agricola.eustachio@hsr.it
J.-J. Rouby Á C. Arbelot
Multidisciplinary Intensive Care Unit,
Department of Anesthesiology,
Pitie´-Salpeˆtrie`re Hospital,
University Pierre and Marie Curie (UPMC),
Paris 6, France
e-mail: jjrouby@invivo.edu
C. Arbelot
e-mail: charlotte.arbelot@psl.aphp.fr
A. Liteplo
Emergency Medicine, Massachusetts
General Hospital, Boston, MA, USA
e-mail: aliteplo@partners.org
A. Sargsyan
Wyle/NASA Lyndon B. Johnson Space
Center Bioastronautics Contract,
Houston, TX, USA
e-mail: ashot.sargsyan@nasa.gov
F. Silva
Department of Emergency Medicine,
UC Davis Medical Center,
Sacramento, CA, USA
e-mail: fernando.silva@winfocus.org
R. Hoppmann
Internal Medicine, University of South
Carolina School of Medicine,
Columbia, SC, USA
e-mail: Richard.hoppmann@uscmed.sc.edu
R. Breitkreutz
Department of Anaesthesiology, Intensive
Care and Pain Therapy, University Hospital
of the Saarland and Frankfurt Institute of
Emergency Medicine and Simulation
Training (FINEST), Homburg, Germany
e-mail: raoul.breitkreutz@gmail.com
A. Seibel
Diakonie Klinikum jung-stilling,
Siegen, Germany
e-mail: arminseibel1@hotmail.com
L. Neri
AREU EMS Public Regional Company,
Niguarda Ca’ Granda Hospital,
Milano, Italy
e-mail: luca.neri@winfocus.org
E. Storti
Intensive Care Unit ‘‘G. Bozza,’’, Niguarda
Ca’ Granda Hospital, Milan, Italy
e-mail: enrico.storti@winfocus.org
T. Petrovic
Samu 93, University Hospital Avicenne,
Bobigny, France
e-mail: tomislav.petrovic@winfocus.org
Abstract Background: The pur-
pose of this study is to provide
evidence-based and expert consensus
recommendations for lung ultrasound
with focus on emergency and critical
care settings. Methods: A multidis-
ciplinary panel of 28 experts from
eight countries was involved. Litera-
ture was reviewed from January 1966
to June 2011. Consensus members
searched multiple databases including
Pubmed, Medline, OVID, Embase,
and others. The process used to
develop these evidence-based recom-
mendations involved two phases:
determining the level of quality of
evidence and developing the recom-
mendation. The quality of evidence is
assessed by the grading of recom-
mendation, assessment, development,
and evaluation (GRADE) method.
However, the GRADE system does
not enforce a specific method on how
the panel should reach decisions
during the consensus process. Our
methodology committee decided to
utilize the RAND appropriateness
method for panel judgment and deci-
sions/consensus. Results: Seventy-
three proposed statements were
examined and discussed in three
conferences held in Bologna, Pisa,
and Rome. Each conference included
two rounds of face-to-face modified
Delphi technique. Anonymous panel
voting followed each round. The
panel did not reach an agreement and
therefore did not adopt any recom-
mendations for six statements. Weak/
conditional recommendations were
made for 2 statements, and strong
recommendations were made for the
remaining 65 statements. The state-
ments were then recategorized and
grouped to their current format.
Internal and external peer-review
processes took place before submis-
sion of the recommendations.
Updates will occur at least every
4 years or whenever significant major
changes in evidence appear. Conclu-
sions: This document reflects the
overall results of the first consensus
conference on ‘‘point-of-care’’ lung
ultrasound. Statements were dis-
cussed and elaborated by experts who
published the vast majority of papers
on clinical use of lung ultrasound in
the last 20 years. Recommendations
were produced to guide implementa-
tion, development, and
standardization of lung ultrasound in
all relevant settings.
Keywords Lung ultrasound Á
Chest sonography Á Emergency
ultrasound Á Critical ultrasound Á
Point-of-care ultrasound Á Guideline Á
RAND Á GRADE Á
Evidence-based medicine
578
3. Introduction
Modern lung ultrasound is mainly applied not only in
critical care, emergency medicine, and trauma surgery,
but also in pulmonary and internal medicine. Many
international authors have produced several studies on
the application of lung ultrasound in various settings.
The emergence of differences in approach, techniques
utilized, and nomenclature, however, provided the
stimulus to initiate a guideline/consensus process with
the aim of elaborating a unified approach and language
for six major areas, namely terminology, technology,
technique, clinical outcomes, cost effectiveness, and
future research. This process was conducted following a
rigorous scientific pathway to produce evidence-based
guidelines containing a list of recommendations for
clinical application of lung ultrasound [1]. A literature
search was performed, and a multidisciplinary, inter-
national panel of experts was identified. The proposed
recommendations represent a framework for ‘‘point-of-
care’’ lung ultrasound intended to standardize its
application around the globe and in different clinical
settings.
This report constitutes a concise, shortened version of
the original document. The electronic version, accessible
online as supplementary material, provides a full expla-
nation of methods and a comprehensive discussion for
each recommendation (see Electronic Supplementary
Material 1).
Methods
Grading of recommendation, assessment, development,
and evaluation (GRADE) method was used to develop
these evidence-based recommendations [2]. The process
involves two phases: (1) determining the level of quality
of evidence, and (2) developing the recommendation.
Relevant articles with clinical outcomes were classified
into three levels of quality based on the criteria of the
GRADE methodology for developing guidelines and
clinical recommendations (Table 1). RAND appropriate-
ness method (RAM) was used within the GRADE steps
that required panel judgment and decisions/consensus [3].
RAM was also used in formulating the recommendations
based purely on expert consensus, such as recommenda-
tions related to terminology. Recommendations were
generated in two classes (strong or weak/conditional)
based on the GRADE criteria taking into consideration
preset rules that defined the panel agreement/consensus
and its degree. The transformation of evidence into rec-
ommendation depends on the evaluation by the panel for
outcome, benefit/cost, and benefit/harm ratios, and cer-
tainty about similarity in values/preferences [2].
Panel selection
Experts were eligible for selection if they had published
as first author a peer-reviewed article on lung ultrasound
during the past 10 years in more than one main topic of
lung ultrasound (pneumothorax, interstitial syndrome,
lung consolidation, monitoring, neonatology, pleural
effusion), taking into consideration the proportionality as
determined by a MEDLINE literature search from 1966 to
October 2010. Methodologists with experience in evi-
dence-based methodology and guideline development
were also included (see ‘‘Appendix’’ for list of partici-
pants, affiliations, and assignments).
Literature search strategy
The literature search was done in two tracks. The experts
themselves, with more than one expert search in each
domain to avoid selection bias, constituted the first track.
An epidemiologist assisted by a professional librarian
performed the second track by conducting literature
search of English-language articles from 1966 to October
2010. See Table 2 for search databases, terms, and the
MeSH headings used. The two bibliographies were
compared for thoroughness and consistency.
Panel meetings and voting
The panel of experts met on three occasions: Bologna
(28–30 November 2009), Pisa (11–12 May 2010), and
Rome (7–9 October 2010). The panelists formulated draft
Table 1 Levels of quality of evidence
Level Pointsb
Quality Interpretation
A C4 High Further research is very unlikely to
change our confidence in the estimate
of effect or accuracy
B 3 Moderate Further research is likely to have an
important impact on our confidence in
the estimate of effect or accuracy and
may change the estimate
Ca
B2 Lowa
Further research is very likely to have
an important impact on our
confidence in the estimate of effect or
accuracy and is likely to change the
estimate. Any estimate of effect or
accuracy is very uncertain (very low)
This table was modified from Guyatt et al. [2]
a
Level C can be divided into low (points = 2) and very low
(points = 1 or less)
b
Points are calculated based on the nine GRADE quality factors
[2]
579
4. recommendations before the conferences, which laid the
foundation to work together and critique the recommen-
dations during the conferences. At each plenary
conference, a representative of each domain presented
potentially controversial issues in the recommendations. A
face-to-face debate took place in two rounds of modified
Delphi technique; after each round, anonymous voting was
conducted. A standardized method for determining the
agreement/disagreement and the degree of agreement and
hence for deciding about the grade of recommendation
(weak versus strong) was then applied [3, 4].
Results
Literature search results
A total of 209 articles and two books were retrieved by
the first track search. An additional 110 articles were
added from the second track over a 1-year period. These
320 references (see Electronic Supplementary Material 1)
were individually appraised based on methodological
criteria to determine the initial quality level. The final
judgment about the quality of evidence-based recom-
mendations was only done after assigning the articles to
each statement/question.
General results
A total number of 73 proposed statements were examined
by 28 experts and discussed in the three conferences.
Each statement was coded with an alphanumeric code,
which includes the following in order of appearance: the
location of the conference (Bologna, B; Pisa, P; Rome,
RL), the number assigned to the domain, and the number
assigned to the statement. Table 3 presents each statement
code with its grade of recommendation, degree of con-
sensus, and level of quality of evidence.
Statements and discussion
Pneumothorax
Technique
Statement code B-D1-S1 (strong recommendation:
level A of evidence)
• The sonographic signs of pneumothorax include the
following:
– Presence of lung point(s)
– Absence of lung sliding
– Absence of B-lines
– Absence of lung pulse
B-D1-S2 (strong: level A)
• In the supine patient, the sonographic technique
consists of exploration of the least gravitationally
dependent areas progressing more laterally.
• Adjunct techniques such as M-mode and color
Doppler may be used.
B-D1-S3 (weak: level C)
• Ultrasound scanning for pneumothorax may be a basic
ultrasound technique with a steep learning curve.
P-D1-S2 (strong: level B)
• During assessment for pneumothorax in adults, a
microconvex probe is preferred. However, other
transducer (e.g., linear array, phased array, convex)
may be chosen based on physician preference and
clinical setting.
Clinical implications
B-D1-S4 (strong: level A)
• Lung ultrasound should be used in clinical settings
when pneumothorax is in the differential diagnosis.
Table 2 Search terms used
MeSH
headings
Terms
Sonography (echographic OR echography OR sonographic OR
sonography OR ultrasonic OR ultrasonographic
OR ultrasonography OR ultrasound).ti
EM/CCM (bedside OR critical OR intensive OR emergency OR
emergent OR urgency OR urgent OR critical OR
critically OR shock OR unstable OR hypotensive
OR hypoperfusion OR sepsis).ti
ECHO (cardiac OR cardiologic OR cardiological
echocardiography OR echocardiographic OR heart
OR pacing OR chest OR lung OR congestive heart
failure OR CHF OR ADHF OR pressure).ti
LUNG (lung OR chest OR thoracic OR transthoracic OR
cardiothoracic OR pleural OR pulmonary OR
pulmonic OR pneumology OR pneumonic OR
alveolar OR interstitial OR pneumothorax OR
hemothorax OR consolidation).ti
OTHER (accuracy OR accurate OR sensitivity OR sensitive
OR specificity OR specific OR predictive OR
predict).ti
COST (cost OR effective OR effectiveness OR efficacy OR
efficacious OR efficient OR efficiency OR benefit
OR value).ti
Search databases: Books@Ovid June 02, 2011; Journals@Ovid Full
Text June 2003, 2011; Your Journals@Ovid; AMED (Allied and
Comp Medicine) 1985 to May 2011; CAB Abstracts Archive
1910–1972; Embase 1980–2011 week 22; ERIC 1965 to May
2011; Health and Psychosocial Instruments 1985 to April 2011;
Ovid MEDLINE(R) In-Process and Other Non-Indexed Citations
and Ovid MEDLINE(R) 1948 to present; Ovid MEDLINE(R) 1948
to May week 4 2011; Social Work Abstracts 1968 to June 2011;
NASW Clinical Register 14th Edition
580
5. Imaging strategies and outcomes
B-D1-S5 (strong: level B)
• Lung ultrasound more accurately rules in the diagno-
sis of pneumothorax than supine anterior chest
radiography (CXR).
B-D1-S6 (strong: level A)
• Lung ultrasound more accurately rules out the diag-
nosis of pneumothorax than supine anterior chest
radiography.
B-D1-S7 (strong: level C)
• Lung ultrasound when compared with supine chest
radiography may be a better diagnostic strategy as an
initial diagnostic study in critically ill patients with
suspected pneumothorax, and may lead to better
patient outcome.
B-D1-S8 (no consensus: level C)
• Lung ultrasound compares well with computer-
ized tomography in assessment of pneumothorax
extension.
P-D1-S1 (no consensus: level C)
• Bedside lung ultrasound is a useful tool to differen-
tiate between small and large pneumothorax, using
detection of the lung point.
Comments The four sonographic signs useful to
diagnose pneumothorax and their usefulness in ruling in
and ruling out the condition are reported in Fig. 1 [5].
Lung sliding is the depiction of a regular rhythmic
Table 3 Summary table for the 73 statements with their level of evidence
SN Statement
code
Recommendation
strength
Degree of
consensus
Level of quality
of evidence
SN Statement
code
Recommendation
strength
Degree of
consensus
Level of quality
of evidence
1 B-D1-S1 Strong Very good A 38 P-D2-S1 Strong Very good N/A
2 B-D1-S2 Strong Very good A 39 P-D2-S2 Strong Very good B
3 B-D1-S3 Weak Some C 40 P-D2-S3 Strong Very good B
4 B-D1-S4 Strong Very good A 41 P-D2-S4 No = disagreement No C
5 B-D1-S5 Strong Very good B 42 P-D3-S1 Strong Very good A
6 B-D1-S6 Strong Good A 43 P-D3-S2 Strong Very good A
7 B-D1-S7 Strong Good C 44 P-D3-S3 Strong Very good B
8 B-D1-S8 No = disagreement No C 45 P-D3-S4 Strong Very good B
9 B-D2-S1 Strong Very good A 46 P-D3-S5 Strong Very good B
10 B-D2-S2 Strong Very good A 47 P-D3-S6 Strong Very good B
11 B-D2-S3 Strong Very good B 48 P-D3-S7 Strong Very good A
12 B-D2-S4 Strong Good B 49 P-D4-S1 Strong Very good B
13 B-D2-S5 Strong Very good B 50 P-D4-S2 Strong Very good B
14 B-D2-S6 Strong Very good B 51 P-D4-S3 Strong Very good B
15 B-D2-S7 No = disagreement No C 52 P-D4-S4 Strong Very good B
16 B-D2-S8 Strong Very good C 53 P-D4-S5 Strong Very good B
17 B-D2-S9 Strong Very good N/A 54 P-D4-S6 Strong Very good B
18 B-D2-S10 Strong Very good N/A 55 P-D4-S7 Strong Very good B
19 B-D3-S1 Strong Very good C 56 P-D4-S8 Strong Very good A
20 B-D3-S2 Weak Some C 57 P-D4-S9 Strong Very good A
21 B-D3-S3 Strong Good N/A 58 P-D5-S1 Strong Very good B
22 B-D3-S4 Strong Very good A 59 RL-D2-S1 Strong Very good A
23 B-D3-S5 Strong Very good A 60 RL-D2-S2 Strong Very good A
24 B-D3-S6 Strong Good B 61 RL-D3-S1 Strong Very good B
25 B-D3-S7 No = disagreement No C 62 RL-D3-S2 Strong Very good B
26 B-D3-S8 Strong Very good A 63 RL-D3-S3 Strong Very good B
27 B-D4-S1 Strong Good A 64 RL-D3-S4 Strong Very good B
28 B-D4-S2 Strong Very good A 65 RL-D3-S5 Strong Very good B
29 B-D4-S3 Strong Very good A 66 RL-D4-S1 Strong Very good B
30 B-D4-S4 Strong Very good A 67 RL-D4-S2 Strong Very good B
31 B-D4-S5 Strong Very good B 68 RL-D4-S3 Strong Very good A
32 B-D4-S6 Strong Very good B 69 RL-D4-S4 Strong Very good A
33 B-D4-S7 Strong Very good A 70 RL-D4-S5 Strong Very good A
34 B-D4-S8 Strong Good C 71 RL-D5-S1 Strong Very good N/A
35 B-D4-S9 No = disagreement No N/A 72 RL-D5-S2 Strong Very good N/A
36 P-D1-S1 No = disagreement No C 73 RL-D6-S1 Strong Good B
37 P-D1-S2 Strong Very good B
No statement for D1 in Rome (removed for duplication); RL-D6-S1 was a revision of P-D2-S4 due to new evidence presented; statement
B-D3-S1 covers information given by statements P-D3-S4 and P-D3-S5; these latter two are not presented in the document
B Bologna, P Pisa, RL Rome-Lung, D domain, S statement, SN statement number, N/A not applicable
581
6. movement synchronized with respiration that occurs
between the parietal and visceral pleura that are either in
direct apposition or separated by a thin layer of intra-
pleural fluid [6–9]. The lung pulse refers to the subtle
rhythmic movement of the visceral upon the parietal
pleura with cardiac oscillations [6, 8, 10]. As B-lines
(well defined elsewhere) originate from the visceral
pleura, their simple presence proves that the visceral
pleura is opposing the parietal, thus excluding pneumo-
thorax at that point. The lung point refers to the depiction
of the typical pattern of pneumothorax, which is simply
the absence of any sliding or moving B-lines at a physical
location where this pattern consistently transitions into an
area of sliding, which represents the physical limit of
pneumothorax as mapped on the chest wall [7, 11, 12].
In extreme emergency, absence of any movement of
the pleural line, either horizontal (sliding) or vertical
(pulse), coupled with absence of B-lines allows prompt
and safe diagnosis of pneumothorax without the need for
searching the lung point.
Lung ultrasound is more accurate than CXR particu-
larly in ruling out pneumothorax [1, 6, 13–17]. There are
some settings where lung ultrasound for pneumothorax is
not only recommended but also essential: cardiac arrest/
unstable patient, radio-occult pneumothorax, and limited-
resource areas.
Disagreement on the steep learning curve of the
technique is based on the fact that the positive predictive
value of ultrasound and its specificity have tended to be
slightly lower than the sensitivity in the studies on
pneumothorax. Consideration has been made that diag-
nosis of pneumothorax can require more nuanced
interpretation of the combination of findings as lung
bullae, contusions, adhesions, and others that can result in
false positives.
Interstitial syndrome
Artifacts and physics
P-D2-S1 [strong: level not applicable (N/A)]
• B-lines are defined as discrete laser-like vertical
hyperechoic reverberation artifacts that arise from
the pleural line (previously described as ‘‘comet
tails’’), extend to the bottom of the screen without
fading, and move synchronously with lung sliding.
RL-D5-S1 (strong: level N/A)
• B-lines are artifacts.
RL-D5-S2 (strong: level N/A)
• The anatomic and physical basis of B-lines is not
known with certainty at this time.
B-D2-S9 (strong: level N/A)
• The term ‘‘sliding’’ (rather than ‘‘gliding’’) should be
used in the description of pleural movement.
Scanning and training methodology
B-D2-S1 (strong: level A)
• Multiple B-lines are the sonographic sign of lung
interstitial syndrome.
B-D2-S2 (strong: level A)
• In the evaluation of interstitial syndrome, the sono-
graphic technique ideally consists of scanning
eight regions, but two other methods have been
described:
– A more rapid anterior two-region scan may be
sufficient in some cases.
– The evaluation of 28 rib interspaces is an
alternative.
• A positive region is defined by the presence of three or
more B-lines in a longitudinal plane between two ribs.
B-D2-S4 (strong: level B)
• In the evaluation of interstitial syndrome, the follow-
ing suggest a positive exam:
– Two or more positive regions (see B-D2-S2)
bilaterally.
– The 28 rib space technique may semiquantify the
interstitial syndrome: in each rib space, count the
Fig. 1 Flow chart on diagnosing pneumothorax. This flow chart
suggests the correct sequence and combination of the four
sonographic signs useful to rule out or rule in pneumothorax
582
7. number of B-lines from zero to ten, or if confluent,
assess the percentage of the rib space occupied by
B-lines and divide it by ten.
B-D2-S10 (strong: level N/A)
• The term ‘‘B-pattern’’ should be used (rather than
‘‘lung rockets’’ or ‘‘B-PLUS’’) in the description of
multiple B-lines in patients with interstitial syndrome.
B-D2-S3 (strong: level B)
• In the evaluation of interstitial syndrome, lung
ultrasound should be considered as a basic technique
with a steep learning curve.
Clinical implications
P-D5-S1 (strong: level B)
• The presence of multiple diffuse bilateral B-lines
indicates interstitial syndrome. Causes of interstitial
syndrome include the following conditions:
– Pulmonary edema of various causes
– Interstitial pneumonia or pneumonitis
– Diffuse parenchymal lung disease (pulmonary
fibrosis)
P-D2-S2 (strong: level B)
• Regarding B-lines, focal multiple B-lines may be
present in a normal lung, and a focal (localized)
sonographic pattern of interstitial syndrome may be
seen in the presence of any of the following:
– Pneumonia and pneumonitis
– Atelectasis
– Pulmonary contusion
– Pulmonary infarction
– Pleural disease
– Neoplasia
RL-D3-S1 (strong: level B)
• Lung ultrasound is a reliable tool to evaluate diffuse
parenchymal lung disease (pulmonary fibrosis).
• The primary sonographic sign to be identified is the
presence of multiple B-lines in a diffuse and nonho-
mogeneous distribution.
• Pleural line abnormalities are often present.
RL-D3-S2 (strong: level B)
• In patients with diffuse parenchymal lung disease
(pulmonary fibrosis), the distribution of B-lines corre-
lates with computed tomography (CT) signs of fibrosis.
RL-D3-S3 (strong: level B)
• In contrast to cardiogenic pulmonary edema, the
sonographic findings that are indicative of diffuse
parenchymal lung disease (pulmonary fibrosis)
include the following:
– Pleural line abnormalities (irregular, fragmented
pleural line)
– Subpleural abnormalities (small echo-poor areas)
– B-lines in a nonhomogeneous distribution
RL-D3-S4 (strong: level B)
• In contrast to cardiogenic pulmonary edema, the
sonographic findings that are indicative of acute
respiratory distress syndrome (ARDS) include the
following:
– Anterior subpleural consolidations
– Absence or reduction of lung sliding
– ‘‘Spared areas’’ of normal parenchyma
– Pleural line abnormalities (irregular thickened
fragmented pleural line)
– Nonhomogeneous distribution of B-lines
Imaging strategies
B-D2-S5 (strong: level B)
• Lung ultrasound is superior to conventional chest
radiography for ruling in significant interstitial
syndrome.
B-D2-S6 (strong: level B)
• In patients with suspected interstitial syndrome, a
negative lung ultrasound examination is superior to
Fig. 2 The four chest areas per side considered for complete eight-
zone lung ultrasound examination. These areas are used to evaluate
for the presence of interstitial syndrome. Areas 1 and 2 denote the
upper anterior and lower anterior chest areas, respectively. Areas 3
and 4 denote the upper lateral and basal lateral chest areas,
respectively. PSL parasternal line, AAL anterior axillary line, PAL
posterior axillary line (modified from Volpicelli et al. [19])
583
8. conventional chest radiography in ruling out signifi-
cant interstitial syndrome.
B-D2-S7 (no consensus: level C)
• Lung ultrasound used as a first-line diagnostic
approach in the evaluation of suspected interstitial
syndrome, when compared with chest radiography,
may lead to better patient outcomes.
P-D2-S3 (strong: level B)
• In resource-limited settings, lung ultrasound should be
considered as a particularly useful diagnostic modality
in the evaluation of interstitial syndrome.
Outcomes
B-D2-S8 (strong: level C)
• Use of sonography in diagnosis of interstitial syn-
drome is likely to improve the care of patients in
whom this diagnosis is a consideration.
B-D4-S5 (strong: level B)
• In suspected decompensated left-sided heart failure,
lung ultrasound should be considered because, with
other bedside tests, it provides additional diagnostic
information about this condition.
Comments Many studies showed a tight correlation
between interstitial involvement of lung diseases and
B-lines [10, 18–20]. The consensus process defined the
basic eight-region sonographic technique (Fig. 2) and the
criteria for positive scan and positive examination [19–
21]. In the critically ill, a more rapid anterior two-region
scan may be sufficient to rule out interstitial syndrome in
cardiogenic acute pulmonary edema [12]. A positive
examination for sonographic diffuse interstitial syndrome
allows bedside distinction between a cardiogenic versus a
respiratory cause of acute dyspnea [22–24]. For more
precise quantification of interstitial syndrome, the
28-scanning-site technique can be useful, especially in
cardiology and nephrology settings [25]. In acute
decompensated heart failure, semiquantification of the
severity of congestion can be calculated by counting the
total number of B-lines (28-scanning-site technique) or
the number of positive scans (eight-region technique) [26,
27]. A focal sonographic pattern of interstitial syndrome
should be differentiated from a diffuse interstitial syn-
drome [21]. Similar B-patterns are observed in many
acute and chronic conditions with diffuse interstitial
involvement [1, 19, 20, 25, 28, 29]. However, some so-
nographic signs other than B-lines are useful to
differentiate the B-pattern of cardiogenic pulmonary
edema, ARDS, and pulmonary fibrosis [10]. The sono-
graphic technique for diagnosis of interstitial syndrome is
a basic technique [30–32] with superiority over conven-
tional CXR [33].
Lung consolidation
Signs and clinical implications
B-D3-S1 (strong: level C) (this statement combines
statements P-D3-S4 and P-D3-S5)
• The sonographic sign of lung consolidation is a
subpleural echo-poor region or one with tissue-like
echotexture.
• Lung consolidations may have a variety of causes
including infection, pulmonary embolism, lung cancer
and metastasis, compression atelectasis, obstructive
atelectasis, and lung contusion. Additional sonograph-
ic signs that may help to determine the cause of lung
consolidation include the following:
– The quality of the deep margins of the consolidation
– The presence of comet-tail reverberation artifacts at
the far-field margin
– The presence of air bronchogram(s)
– The presence of fluid bronchogram(s)
– The vascular pattern within the consolidation.
B-D3-S4 (strong: level A)
• Lung ultrasound for detection of lung consolidation
can be used in any clinical setting including point-of-
care examination.
B-D3-S8 (strong: level A)
• Lung ultrasound should be used in the evaluation of
lung consolidation because it can differentiate con-
solidations due to pulmonary embolism, pneumonia,
or atelectasis.
P-D3-S6 (strong: level B)
• Lung ultrasound is a clinically useful diagnostic tool
in patients with suspected pulmonary embolism.
P-D3-S7 (strong: level A)
• Lung ultrasound is an alternative diagnostic tool to
computerized tomography in diagnosis of pulmonary
embolism when CT is contraindicated or unavailable.
P-D3-S3 (strong: level B)
• Lung ultrasound is a clinically useful tool to rule in
pneumonia; however, lung ultrasound does not rule
out consolidations that do not reach the pleura.
B-D4-S8 (strong: level C)
• Lower-frequency ultrasound scanning may allow for
better evaluation of the extent of a consolidation.
Imaging strategies and learning curve
B-D3-S5 (strong: level A)
584
9. • Lung ultrasound should be considered as an accurate
tool in ruling in lung consolidation when compared
with chest radiography.
B-D3-S6 (strong: level B)
• Lung ultrasound may be considered as an accurate
tool in ruling out lung consolidation in comparison
with chest radiography.
B-D3-S7 (no consensus: level C)
• Use of lung ultrasound as an initial diagnostic strategy
in the evaluation of lung consolidation improves
outcomes in comparison with chest radiography.
B-D3-S3 (strong: level N/A)
• Ultrasound diagnosis of lung consolidation may be
considered as a basic sonographic technique with a
steep learning curve.
B-D4-S6 (strong: level B)
• Lung ultrasound should be considered in the detection
of radio-occult pulmonary conditions in patients with
pleuritic pain.
B-D3-S2 (weak: level C)
• In the evaluation of lung consolidation, the sono-
graphic technique should commence with the
examination of areas of interest (if present, e.g., area
of pain) then progress to the entire lung, as needed.
B-D4-S3 (strong: level A)
• In mechanically ventilated patients, lung ultrasound
should be considered because it is more accurate than
chest radiography in distinguishing various types of
consolidations.
B-D4-S4 (strong: level A)
• In mechanically ventilated patients lung ultrasound
should be considered as it is more accurate than
portable chest radiography in the detection of
consolidation.
B-D4-S9 (no consensus: level N/A)
• Lung ultrasound is accurate in distinguishing various
types of consolidations in comparison with CT scan in
mechanically ventilated patients.
Comments The consolidated region of the lung is
visualized at lung ultrasound as an echo-poor or tissue-
like image, depending on the extent of air loss and fluid
predominance, which is clearly different from the normal
pattern [34–38]. The cause of lung consolidation can be
diagnosed by analyzing the sonographic features of the
lesion [39, 40]. Accuracy of lung ultrasound in the diag-
nosis and differential diagnosis of lung consolidation has
been tested in different settings [36, 41–44] and showed
good accuracy compared with CXR [43, 45–48]. In
pleuritic pain, lung ultrasound is superior to CXR and
may allow visualization of radio-occult pulmonary con-
ditions [47, 48]. In mechanically ventilated patients,
lung ultrasound is more accurate than CXR in detecting
and distinguishing various types of consolidations
[49, 50].
Monitoring lung diseases
B-D4-S1 (strong: level A)
• In patients with cardiogenic pulmonary edema, semi-
quantification of disease severity may be obtained by
evaluating the number of B-lines as this is directly
proportional to the severity of congestion.
B-D4-S2 (strong: level A)
• In patients with cardiogenic pulmonary edema,
B-lines should be evaluated because it allows moni-
toring of response to therapy.
P-D3-S1 (strong: level A)
• In patients with increased extravascular lung water,
assessment of lung reaeration can be assessed by
demonstrating a change (decrease) in the number of
B-lines.
P-D3-S2 (strong: level A)
• In the majority of cases of acute lung injury or ARDS,
ultrasound quantification of lung reaeration may be
assessed by tracking changes in sonographic findings.
• Sonographic findings should include assessment of
lung consolidation and B-lines.
RL-D2-S1 (strong: level A)
• In critically ill patients with acute lung injury or
ARDS, ultrasound changes in lung aeration can be
semiquantitatively assessed (at a given location on the
chest) using the following four sonographic findings,
often in progression:
– Normal pattern
– Multiple spaced B-lines
– Coalescent B-lines
– Consolidation
RL-D2-S2 (strong: level A)
• Lung ultrasound is able to monitor aeration changes
and the effects of therapy in a number of acute lung
diseases, including the following:
– Acute pulmonary edema
– Acute respiratory distress syndrome
– Acute lung injury
– Community-acquired pneumonia
– Ventilator-associated pneumonia
585
10. – Recovery from lavage of alveolar proteinosis
RL-D3-S5 (strong: level B)
• Serial evaluation of B-lines allows monitoring of
pulmonary congestion in patients on hemodialysis, but
is of undetermined clinical utility.
P-D2-S4 (no consensus: level C)
• The semiquantitative techniques of B-line evaluation
(see B-D2-S2 and B-D2-S4) are useful as a prognostic
indicator of outcomes or mortality in patients with
left-sided heart failure.
RL-D6-S1 (strong: level B)
• Semiquantitative B-line assessment is a prognostic
indicator of adverse outcomes and mortality in
patients with acute decompensated heart failure.
Comments The concept of using lung ultrasound for
monitoring the patient is one of the major innovations that
emerged from recent studies. Pulmonary congestion may
be semiquantified using lung ultrasound [22, 25, 27, 51–
55]. In the clinical arena, lung ultrasound can therefore be
employed as a bedside, easy-to-use, alternative tool for
monitoring pulmonary congestion changes in heart failure
patients, as they disappear or clear upon adequate medical
treatment [27, 56–60]. More generally, any significant
change in lung aeration resulting from any therapy aimed
at reversing aeration loss might be detected by corre-
sponding changes in lung ultrasound patterns [61, 62].
Neonatology and pediatrics
P-D4-S1 (strong: level B)
• Lung ultrasound is a clinically useful diagnostic tool
in neonates with suspected respiratory distress syn-
drome (RDS).
P-D4-S2 (strong: level B)
• All the following sonographic signs are likely to be
present in neonates with respiratory distress syndrome:
– Pleural line abnormalities
– Absence of spared areas
– Bilateral confluent B-lines
P-D4-S3 (strong: level B)
• Lung ultrasound is as accurate as chest radiography in
the diagnosis of respiratory distress syndrome in
neonates.
P-D4-S4 (strong: level B)
• Lung ultrasound is a clinically useful diagnostic tool
in suspected transient tachypnea of the newborn
(TTN).
P-D4-S5 (strong: level B)
• The sonographic signs for transient tachypnea of the
newborn are bilateral confluent B-lines in the depen-
dent areas of the lung (‘‘white lung’’) and normal or
near-normal appearance of the lung in the superior
fields.
P-D4-S6 (strong: level B)
• Lung ultrasound is as accurate as chest radiography in
diagnosis of TTN.
P-D4-S7 (strong: level B)
• Lung ultrasound is a clinically useful diagnostic tool
in pediatric patients with suspected pneumonia.
P-D4-S8 (strong: level A)
• The ultrasound signs of lung and pleural diseases
described in adults are also found in pediatric patients.
P-D4-S9 (strong: level A)
• Lung ultrasound is as accurate as chest radiography in
diagnosis of pneumonia in pediatric patients.
Comments In newborns, lung ultrasound signs are
similar to those previously described in adults, although
these signs will be context specific. Lung ultrasound
allows diagnosis of RDS with accuracy similar to CXR
even if there is no correlation between the different
radiographic stages of RDS and ultrasound findings [63].
Lung ultrasound demonstrates very unique findings in the
diagnosis of TTN, whereas CXR is nonspecific [64].
Many studies showed that the ultrasound signs of lung
and pleural diseases described in adults are also found in
pediatric patients [45, 65–68]. In suspected pneumonia,
lung ultrasound has demonstrated to be no less accurate
than CXR. These data suggest that, when there is clinical
suspicion of pneumonia, a positive lung ultrasound
excludes the need to perform CXR.
Pleural effusion
RL-D4-S3 (strong: level A)
• Both of the following signs are present in almost all
free effusions:
– A space (usually anechoic) between the parietal and
visceral pleura
– Respiratory movement of the lung within the
effusion (‘‘sinusoid sign’’)
RL-D4-S5 (strong: level A)
• A pleural effusion with internal echoes suggests that it
is an exudate or hemorrhage. While most transudates
are anechoic, some exudates are also anechoic. Tho-
racentesis may be needed for further characterization.
586
11. RL-D4-S1 (strong: level B)
• In the evaluation of pleural effusion in adults, the
microconvex transducer is preferable. If not available, a
phased array or a convex transducer can be used.
RL-D4-S2 (strong: level B)
• The optimal site to detect a nonloculated pleural
effusion is at the posterior axillary line above the
diaphragm.
RL-D4-S4 (strong: level A)
• For the detection of effusion, lung ultrasound is more
accurate than supine radiography and is as accurate as
CT.
B-D4-S7 (strong: level A)
• In opacities identified by chest radiography, lung
ultrasound should be used because it is more accurate
than chest radiography in distinguishing between
effusion and consolidation.
Comments Pleural effusion is usually visualized as an
anechoic space between the parietal and visceral pleura.
This condition can be obvious in patients with substantial
effusion. In other conditions, such as complex effusion
and in patients where pleural effusion is suspected, the
sonographic technique can benefit from standardized
criteria to improve diagnostic accuracy. The sinusoid sign
is a dynamic sign showing the variation of the interpleural
distance during the respiratory cycles [69, 70]. This var-
iation is easily visualized on M-mode as a sinusoid
movement of the visceral pleura [70].
Lung ultrasound has the potential also for diagnosing
the nature of the effusion [71]. Visualization of internal
echoes, either of mobile particles or septa, is highly
suggestive of exudate or hemothorax [72–76]. However,
when faced with an anechoic effusion, the only way to
differentiate between transudate and exudate is to use
thoracentesis or alternatively to evaluate effusion in the
clinical context [71, 77–79].
Lung ultrasound accuracy is proved to be higher than
CXR, particularly when anterior–posterior view in the
supine patient is considered [49, 69, 70]. Lung ultrasound
performance is nearly as good as CT scan [49, 80].
Update plan
New research and knowledge will give impetus to update
these guidelines by renewing the development process at
least every 4 years or whenever a significant major change
in evidence appears. A professional librarian will review
literature on a regular basis and send any updates to the
corresponding author. The panel is open to new inputs, and
the position of new researchers and experts will be con-
sidered in the future before the next revision.
Conclusions
This is the first document reporting evidence-based rec-
ommendations on clinical use of point-of-care lung
ultrasound. Experts who published the vast majority of
papers on clinical use of lung ultrasound in the last
20 years elaborated these specific 73 recommendations. A
number of these recommendations will potentially
reshape the future practice and knowledge of this rapidly
expanding field. These applications will benefit patients
worldwide as rigorous assessment, classification, and
publication efforts continue to make this critical infor-
mation available to all clinicians. The advantages of
correct use of bedside lung ultrasound in the emergency
setting are striking, particularly in terms of saving from
radiation exposure, delaying or even avoiding transpor-
tation to the radiology suite, and guiding life-saving
therapies in extreme emergency. This document was
elaborated to guide implementation, development, and
training on use of lung ultrasound in all relevant settings;
it will also serve as the basis for further research and to
influence and enhance the associated standards of care.
Appendix
Organizing society
World Interactive Network Focused on Critical Ultra-
sound (WINFOCUS)
Consensus conference participants and affiliations
Working subgroup leaders
Writing committee: G Volpicelli (Emergency Medicine,
San Luigi Gonzaga University Hospital, Torino, Italy)
Document reviewers: M Blaivas (Department of
Emergency Medicine, Northside Hospital Forsyth, Atlanta,
GA, USA)
Methodology committee: M Elbarbary (National & Gulf
Center for Evidence Based Health Practice, King Saud
University for Health Sciences, Riyadh, Saudi Arabia)
Organizing committee: L Neri (AREU EMS Public
Regional Company, Niguarda Ca’ Granda Hospital, Mi-
lano, Italy)
Working committees
Writing committee:
• DA Lichtenstein (Service de Re´animation Me´dicale,
Hoˆpital Ambroise-Pare´, Boulogne, Paris-Ouest,
France)
587
12. • G Mathis (Internal Medicine Praxis, Rankweil, Austria)
• A Kirkpatrick (Foothills Medical Centre, Calgary, AB,
Canada)
• L Gargani (Institute of Clinical Physiology, National
Research Council, Pisa, Italy)
• VE Noble (Division of Emergency Ultrasound, Depart-
ment of Emergency Medicine, Massachusetts General
Hospital, Boston, MA, USA)
• R Copetti (Medical Department, Latisana Hospital,
Udine, Italy)
• G Soldati (Emergency Medicine Unit, Valle del
Serchio General Hospital, Lucca, Italy)
• B Bouhemad (Surgical Intensive Care Unit, Depart-
ment of Anesthesia and Critical Care, Groupe
Hospitalier Paris Saint-Joseph, Paris, France)
• A Reissig (Department of Pneumology and Allergol-
ogy, Medical University Clinic I, Friedrich-Schiller
University, Jena, Germany)
• JJ Rouby (Multidisciplinary Intensive Care Unit,
Department of Anesthesiology, Pitie´-Salpeˆtrie`re Hos-
pital, University Pierre and Marie Curie, Paris, France)
Document reviewers:
• G Via (IRCCS Foundation Policlinico San Matteo,
Pavia, Italy)
• E Agricola (Division of Noninvasive Cardiology, San
Raffaele Scientific Institute, IRCCS, Milan, Italy)
• JW Tsung (Mount Sinai School of Medicine, Depart-
ments of Emergency Medicine and Pediatrics, New
York, NY, USA)
Methodology committee:
• L Melniker (Department of Emergency Medicine, New
York Methodist Hospital and Clinical Epidemiology
Unit, Division of General Internal Medicine, Depart-
ment of Medicine, Weill Medical College of Cornell
University, NY, USA)
• A Dean (Division of Emergency Ultrasonography,
Department of Emergency Medicine, University of
Pennsylvania Medical Center, Philadelphia, PA, USA)
• R Breitkreutz [Department of Anaesthesiology, Inten-
sive Care and Pain therapy, University Hospital of the
Saarland and Frankfurt Institute of Emergency Medi-
cine and Simulation Training (FINEST), Germany]
• A Seibel (Diakonie Klinikum jung-stilling, Siegen,
Germany)
Organizing committee:
• E Storti (Intensive Care Unit ‘‘G. Bozza,’’ Niguarda
Ca’ Granda Hospital, Milan, Italy)
• T Petrovic (Samu 93, University Hospital Avicenne,
Bobigny, France)
Other consensus conference members:
• C Arbelot (Multidisciplinary Intensive Care Unit,
Department of Anesthesiology, Pitie´-Salpeˆtrie`re Hos-
pital, University Pierre and Marie Curie, Paris, France)
• A Liteplo (Emergency Medicine, Massachusetts Gen-
eral Hospital, Boston, MA, USA)
• A Sargsyan (Wyle/NASA Lyndon B. Johnson Space
Center Bioastronautics Contract, Houston, TX, USA)
• F Silva (UC Davis Medical Center, Emergency Med-
icine, Sacramento, CA, USA)
• R Hoppmann (Internal Medicine, University of South
Carolina School of Medicine)
Acknowledgments Special thanks to the Cornell library staff for
conducting the literature search, to Ms. Maddalena Bracchetti for
her outstanding organizational and administrative support, and to
all the secretariat staff. This study was endorsed by the World
Interactive Network Focused on Critical Ultrasound (WINFOCUS).
Conflicts of interest The authors declare that they have no
competing interests.
References
1. Elbarbary M, Melniker LA, Volpicelli
G, Neri L, Petrovic T, Storti E, Blaivas
M (2010) Development of evidence-
based clinical recommendations and
consensus statements in critical
ultrasound field: why and how? Crit
Ultrasound J 2:93–95
2. Guyatt GH, Oxman AD, Schunemann
HJ, Tugwell P, Knottnerus A (2011)
GRADE guidelines: a new series of
articles in the Journal of Clinical
Epidemiology. J Clin Epidemiol
64:380–382
3. Fitch K, Bernstein SJ, Aguilar MD,
Burnand B, LaCalle JR, Lazaro P, van
het Loo M, McDonnell J, Vader JP,
Kahan JP (2001) The RAND/UCLA
appropriateness method user’s manual.
RAND Corporation, Arlington
4. Baumann MH, Strange C, Heffner JE,
Light R, Kirby TJ, Klein J, Luketich JD,
Panacek EA, Sahn SA (2001)
Management of spontaneous
pneumothorax: an American College of
Chest Physicians Delphi consensus
statement. Chest 119:590–602
5. Volpicelli G (2011) Sonographic
diagnosis of pneumothorax. Intensive
Care Med 37:224–232
6. Kirkpatrick AW, Sirois M, Laupland
KB, Liu D, Rowan K, Ball CG, Hameed
SM, Brown R, Simons R, Dulchavsky
SA, Hamiilton DR, Nicolaou S (2004)
Hand-held thoracic sonography for
detecting post-traumatic
pneumothoraces: the extended focused
assessment with sonography for trauma
(EFAST). J Trauma 57:288–295
7. Lichtenstein D, Meziere G, Biderman
P, Gepner A (2000) The ‘‘lung point’’:
an ultrasound sign specific to
pneumothorax. Intensive Care Med
26:1434–1440
588
13. 8. Lichtenstein DA, Lascols N, Prin S,
Meziere G (2003) The ‘‘lung pulse’’: an
early ultrasound sign of complete
atelectasis. Intensive Care Med
29:2187–2192
9. Lichtenstein DA, Menu Y (1995) A
bedside ultrasound sign ruling out
pneumothorax in the critically ill. Lung
sliding. Chest 108:1345–1348
10. Copetti R, Soldati G, Copetti P (2008)
Chest sonography: a useful tool to
differentiate acute cardiogenic
pulmonary edema from acute
respiratory distress syndrome.
Cardiovasc Ultrasound 6:16
11. Gillman LM, Alkadi A, Kirkpatrick
AW (2009) The ‘‘pseudo-lung point’’
sign: all focal respiratory coupled
alternating pleural patterns are not
diagnostic of a pneumothorax.
J Trauma 67:672–673
12. Lichtenstein DA, Meziere GA (2008)
Relevance of lung ultrasound in the
diagnosis of acute respiratory failure:
the BLUE protocol. Chest 134:117–125
13. Blaivas M, Lyon M, Duggal S (2005) A
prospective comparison of supine chest
radiography and bedside ultrasound for
the diagnosis of traumatic
pneumothorax. Acad Emerg Med
12:844–849
14. Rowan KR, Kirkpatrick AW, Liu D,
Forkheim KE, Mayo JR, Nicolaou S
(2002) Traumatic pneumothorax
detection with thoracic US: correlation
with chest radiography and CT—initial
experience. Radiology 225:210–214
15. Soldati G, Testa A, Pignataro G, Portale
G, Biasucci DG, Leone A, Silveri NG
(2006) The ultrasonographic deep
sulcus sign in traumatic pneumothorax.
Ultrasound Med Biol 32:1157–1163
16. Soldati G, Testa A, Sher S, Pignataro G,
La Sala M, Silveri NG (2008) Occult
traumatic pneumothorax: diagnostic
accuracy of lung ultrasonography in the
emergency department. Chest
133:204–211
17. Zhang M, Liu ZH, Yang JX, Gan JX,
Xu SW, You XD, Jiang GY (2006)
Rapid detection of pneumothorax by
ultrasonography in patients with
multiple trauma. Crit Care 10:R112
18. Soldati G, Testa A, Silva FR, Carbone
L, Portale G, Silveri NG (2006) Chest
ultrasonography in lung contusion.
Chest 130:533–538
19. Volpicelli G, Mussa A, Garofalo G,
Cardinale L, Casoli G, Perotto F, Fava
C, Frascisco M (2006) Bedside lung
ultrasound in the assessment of
alveolar-interstitial syndrome. Am J
Emerg Med 24:689–696
20. Lichtenstein D, Meziere G, Biderman
P, Gepner A, Barre O (1997) The
comet-tail artifact. An ultrasound sign
of alveolar-interstitial syndrome. Am J
Respir Crit Care Med 156:1640–1646
21. Volpicelli G, Caramello V, Cardinale L,
Mussa A, Bar F, Frascisco MF (2008)
Detection of sonographic B-lines in
patients with normal lung or
radiographic alveolar consolidation.
Med Sci Monit 14:CR122–CR128
22. Gargani L, Frassi F, Soldati G, Tesorio
P, Gheorghiade M, Picano E (2008)
Ultrasound lung comets for the
differential diagnosis of acute
cardiogenic dyspnoea: a comparison
with natriuretic peptides. Eur J Heart
Fail 10:70–77
23. Liteplo AS, Marill KA, Villen T, Miller
RM, Murray AF, Croft PE, Capp R,
Noble VE (2009) Emergency thoracic
ultrasound in the differentiation of the
etiology of shortness of breath
(ETUDES): sonographic B-lines and
N-terminal pro-brain-type natriuretic
peptide in diagnosing congestive heart
failure. Acad Emerg Med 16:201–210
24. Volpicelli G, Cardinale L, Garofalo G,
Veltri A (2008) Usefulness of lung
ultrasound in the bedside distinction
between pulmonary edema and
exacerbation of COPD. Emerg Radiol
15:145–151
25. Jambrik Z, Monti S, Coppola V,
Agricola E, Mottola G, Miniati M,
Picano E (2004) Usefulness of
ultrasound lung comets as a
nonradiologic sign of extravascular
lung water. Am J Cardiol 93:1265–1270
26. Picano E, Frassi F, Agricola E,
Gligorova S, Gargani L, Mottola G
(2006) Ultrasound lung comets: a
clinically useful sign of extravascular
lung water. J Am Soc Echocardiogr
19:356–363
27. Volpicelli G, Caramello V, Cardinale L,
Mussa A, Bar F, Frascisco MF (2008)
Bedside ultrasound of the lung for the
monitoring of acute decompensated
heart failure. Am J Emerg Med
26:585–591
28. Reissig A, Kroegel C (2003)
Transthoracic sonography of diffuse
parenchymal lung disease: the role of
comet tail artifacts. J Ultrasound Med
22:173–180
29. Soldati G, Copetti R, Sher S (2009)
Sonographic interstitial syndrome: the
sound of lung water. J Ultrasound Med
28:163–174
30. Bedetti G, Gargani L, Corbisiero A,
Frassi F, Poggianti E, Mottola G (2006)
Evaluation of ultrasound lung comets
by hand-held echocardiography.
Cardiovasc Ultrasound 4:34
31. Noble VE, Lamhaut L, Capp R, Bosson
N, Liteplo A, Marx JS, Carli P (2009)
Evaluation of a thoracic ultrasound
training module for the detection of
pneumothorax and pulmonary edema
by prehospital physician care providers.
BMC Med Educ 9:3
32. Sicari R, Galderisi M, Voigt JU, Habib
G, Zamorano JL, Lancellotti P, Badano
LP (2011) The use of pocket-size
imaging devices: a position statement of
the European Association of
Echocardiography. Eur J Echocardiogr
12:85–87
33. Zanobetti M, Poggioni C, Pini R (2011)
Can chest ultrasonography replace
standard chest radiography for
evaluation of acute dyspnea in the ED?
Chest 139:1140–1147
34. Arbelot C, Ferrari F, Bouhemad B,
Rouby JJ (2008) Lung ultrasound in
acute respiratory distress syndrome and
acute lung injury. Curr Opin Crit Care
14:70–74
35. Bouhemad B, Zhang M, Lu Q, Rouby JJ
(2007) Clinical review: bedside lung
ultrasound in critical care practice. Crit
Care 11:205
36. Gehmacher O, Mathis G, Kopf A,
Scheier M (1995) Ultrasound imaging
of pneumonia. Ultrasound Med Biol
21:1119–1122
37. Lichtenstein DA (2007) Ultrasound in
the management of thoracic disease.
Crit Care Med 35:S250–S261
38. Volpicelli G, Silva F, Radeos M (2010)
Real-time lung ultrasound for the
diagnosis of alveolar consolidation and
interstitial syndrome in the emergency
department. Eur J Emerg Med 17:63–72
39. Lichtenstein D, Meziere G, Seitz J
(2009) The dynamic air bronchogram.
A lung ultrasound sign of alveolar
consolidation ruling out atelectasis.
Chest 135:1421–1425
40. Reissig A, Kroegel C (2003)
Transthoracic ultrasound of lung and
pleura in the diagnosis of pulmonary
embolism: a novel non-invasive bedside
approach. Respiration 70:441–452
41. Lichtenstein DA, Lascols N, Meziere G,
Gepner A (2004) Ultrasound diagnosis
of alveolar consolidation in the
critically ill. Intensive Care Med
30:276–281
42. Mathis G, Blank W, Reissig A,
Lechleitner P, Reuss J, Schuler A,
Beckh S (2005) Thoracic ultrasound for
diagnosing pulmonary embolism: a
prospective multicenter study of 352
patients. Chest 128:1531–1538
43. Parlamento S, Copetti R, Di
Bartolomeo S (2009) Evaluation of lung
ultrasound for the diagnosis of
pneumonia in the ED. Am J Emerg Med
27:379–384
589
14. 44. Reissig A, Kroegel C (2007)
Sonographic diagnosis and follow-up of
pneumonia: a prospective study.
Respiration 74:537–547
45. Copetti R, Cattarossi L (2008)
Ultrasound diagnosis of pneumonia in
children. Radiol Med 113:190–198
46. Reissig A, Mempel C, Copetti R, Groß
F, Neumann R, Mathis G, Kroegel C
(2010) Temporary results (05/2010) of
the multicentre DEGUM-/O¨ GUM-
study: role of chest ultrasound in
diagnosing and follow-up of
pneumonia. Ultraschall Med 31:S65
47. Volpicelli G, Caramello V, Cardinale L,
Cravino M (2008) Diagnosis of radio-
occult pulmonary conditions by real-
time chest ultrasonography in patients
with pleuritic pain. Ultrasound Med
Biol 34:1717–1723
48. Volpicelli G, Cardinale L, Berchialla P,
Mussa A, Bar F, Frascisco MF (2011) A
comparison of different diagnostic tests
in the bedside evaluation of pleuritic
pain in the ED. Am J Emerg Med. doi:
101016/jajem201011035
49. Lichtenstein D, Goldstein I, Mourgeon
E, Cluzel P, Grenier P, Rouby JJ (2004)
Comparative diagnostic performances
of auscultation, chest radiography, and
lung ultrasonography in acute
respiratory distress syndrome.
Anesthesiology 100:9–15
50. Peris A, Tutino L, Zagli G, Batacchi S,
Cianchi G, Spina R, Bonizzoli M,
Migliaccio L, Perretta L, Bartolini M,
Ban K, Balik M (2010) The use of
point-of-care bedside lung ultrasound
significantly reduces the number of
radiographs and computed tomography
scans in critically ill patients. Anesth
Analg 111:687–692
51. Agricola E, Bove T, Oppizzi M, Marino
G, Zangrillo A, Margonato A, Picano E
(2005) ‘‘Ultrasound comet-tail
images’’: a marker of pulmonary
edema: a comparative study with wedge
pressure and extravascular lung water.
Chest 127:1690–1695
52. Agricola E, Picano E, Oppizzi M,
Pisani M, Meris A, Fragasso G,
Margonato A (2006) Assessment of
stress-induced pulmonary interstitial
edema by chest ultrasound during
exercise echocardiography and its
correlation with left ventricular
function. J Am Soc Echocardiogr
19:457–463
53. Fagenholz PJ, Gutman JA, Murray AF,
Noble VE, Thomas SH, Harris NS
(2007) Chest ultrasonography for the
diagnosis and monitoring of high-
altitude pulmonary edema. Chest
131:1013–1018
54. Frassi F, Gargani L, Gligorova S,
Ciampi Q, Mottola G, Picano E (2007)
Clinical and echocardiographic
determinants of ultrasound lung comets.
Eur J Echocardiogr 8:474–479
55. Via G, Lichtenstein D, Mojoli F, Rodi
G, Neri L, Storti E, Klersy C, Iotti G,
Braschi A (2010) Whole lung lavage: a
unique model for ultrasound assessment
of lung aeration changes. Intensive Care
Med 36:999–1007
56. Gargani L (2011) Lung ultrasound: a
new tool for the cardiologist.
Cardiovasc Ultrasound 9:6
57. Liteplo AS, Murray AF, Kimberly HH,
Noble VE (2010) Real-time resolution
of sonographic B-lines in a patient with
pulmonary edema on continuous
positive airway pressure. Am J Emerg
Med 28:541.e5–541.e8
58. Mallamaci F, Benedetto FA, Tripepi R,
Rastelli S, Castellino P, Tripepi G,
Picano E, Zoccali C (2010) Detection of
pulmonary congestion by chest
ultrasound in dialysis patients. JACC
Cardiovasc Imaging 3:586–594
59. Noble VE, Murray AF, Capp R, Sylvia-
Reardon MH, Steele DJ, Liteplo A
(2009) Ultrasound assessment for
extravascular lung water in patients
undergoing hemodialysis. Time course
for resolution. Chest 135:1433–1439
60. Picano E, Gargani L, Gheorghiade M
(2010) Why, when, and how to assess
pulmonary congestion in heart failure:
pathophysiological, clinical, and
methodological implications. Heart Fail
Rev 15:63–72
61. Bouhemad B, Brisson H, Le-Guen M,
Arbelot C, Lu Q, Rouby JJ (2011)
Bedside ultrasound assessment of
positive end-expiratory pressure-
induced lung recruitment. Am J Respir
Crit Care Med 183:341–347
62. Bouhemad B, Liu ZH, Arbelot C,
Zhang M, Ferarri F, Le-Guen M, Girard
M, Lu Q, Rouby JJ (2010) Ultrasound
assessment of antibiotic-induced
pulmonary reaeration in ventilator-
associated pneumonia. Crit Care Med
38:84–92
63. Copetti R, Cattarossi L, Macagno F,
Violino M, Furlan R (2008) Lung
ultrasound in respiratory distress
syndrome: a useful tool for early
diagnosis. Neonatology 94:52–59
64. Copetti R, Cattarossi L (2007) The
‘double lung point’: an ultrasound sign
diagnostic of transient tachypnea of the
newborn. Neonatology 91:203–209
65. Coley BD (2005) Pediatric chest
ultrasound. Radiol Clin North Am
43:405–418
66. Iuri D, De Candia A, Bazzocchi M
(2009) Evaluation of the lung in
children with suspected pneumonia:
usefulness of ultrasonography. Radiol
Med 114:321–330
67. Lichtenstein DA (2009) Ultrasound
examination of the lungs in the
intensive care unit. Pediatr Crit Care
Med 10:693–698
68. Riccabona M (2008) Ultrasound of the
chest in children (mediastinum
excluded). Eur Radiol 18:390–399
69. Kocijancic I, Vidmar K, Ivanovi-
Herceg Z (2003) Chest sonography
versus lateral decubitus radiography in
the diagnosis of small pleural effusions.
J Clin Ultrasound 31:69–74
70. Lichtenstein D, Hulot JS, Rabiller A,
Tostivint I, Meziere G (1999)
Feasibility and safety of ultrasound-
aided thoracentesis in mechanically
ventilated patients. Intensive Care Med
25:955–958
71. Sajadieh H, Afzali F, Sajadieh V,
Sajadieh A (2004) Ultrasound as an
alternative to aspiration for determining
the nature of pleural effusion, especially
in older people. Ann N Y Acad Sci
1019:585–592
72. Chian CF, Su WL, Soh LH, Yan HC,
Perng WC, Wu CP (2004) Echogenic
swirling pattern as a predictor of
malignant pleural effusions in patients
with malignancies. Chest 126:129–134
73. Gorg C, Restrepo I, Schwerk WB
(1997) Sonography of malignant pleural
effusion. Eur Radiol 7:1195–1198
74. Qureshi NR, Rahman NM, Gleeson FV
(2009) Thoracic ultrasound in the
diagnosis of malignant pleural effusion.
Thorax 64:139–143
75. Tu CY, Hsu WH, Hsia TC, Chen HJ,
Tsai KD, Hung CW, Shih CM (2004)
Pleural effusions in febrile medical ICU
patients: chest ultrasound study. Chest
126:1274–1280
76. Yang PC, Luh KT, Chang DB, Wu HD,
Yu CJ, Kuo SH (1992) Value of
sonography in determining the nature of
pleural effusion: analysis of 320 cases.
AJR Am J Roentgenol 159:29–33
77. Brooks A, Davies B, Smethhurst M,
Connolly J (2004) Emergency
ultrasound in the acute assessment of
haemothorax. Emerg Med J 21:44–46
590
15. 78. Chen HJ, Tu CY, Ling SJ, Chen W,
Chiu KL, Hsia TC, Shih CM, Hsu WH
(2008) Sonographic appearances in
transudative pleural effusions: not
always an anechoic pattern. Ultrasound
Med Biol 34:362–369
79. Ma OJ, Mateer JR (1997) Trauma
ultrasound examination versus chest
radiography in the detection of
hemothorax. Ann Emerg Med
29:312–315
80. Rocco M, Carbone I, Morelli A,
Bertoletti L, Rossi S, Vitale M, Montini
L, Passariello R, Pietropaoli P (2008)
Diagnostic accuracy of bedside
ultrasonography in the ICU: feasibility
of detecting pulmonary effusion and
lung contusion in patients on respiratory
support after severe blunt thoracic
trauma. Acta Anaesthesiol Scand
52:776–784
591